Archive for September, 2014

(MOVE) News Corp To Acquire Move, Inc.

News Corp and Move, Inc. (“Move”) announced today that News Corp has agreed to acquire Move, a leading online real estate business that brings consumers and Realtors® together to facilitate the sale and rental of real estate in the United States.

REA Group Limited (“REA”), which is 61.6% owned by News Corp and is the operator of the leading Australian residential property website, realestate.com.au, plans to hold a 20% stake in Move with 80% held by News Corp.

Through realtor.com® and its mobile applications, Move displays more than 98% of all for-sale properties listed in the US, sourced directly from relationships with more than 800 Multiple Listing Services (“MLS”) across the country. As a result, Move has the most up-to-date and accurate for-sale listings of any online real estate company in America. The Move Network of websites, which also includes Move.com, reaches approximately 35 million people per month, who spend an average of 22 minutes each on its sites1.

Move’s content advantage makes it well positioned to capitalize on the fast-growing US online real estate sector and the world’s largest residential real estate market. More than five million homes in the United States are bought and sold each year, representing more than $1 trillion in annual transaction volume. Agents and brokers are expected to spend approximately $14 billion in 2014 marketing homes (up from approximately $11 billion in 2012), and an additional $11 billion will be spent by mortgage providers2.

Under the acquisition agreement, which has been unanimously approved by the board of directors of Move, News Corp will acquire all the outstanding shares of Move for $21 per share, or approximately $950 million (net of Move’s existing cash balance), via an all-cash tender offer. This represents a premium of 37% over Move’s closing stock price on September 29, 2014. REA’s share will be acquired for approximately US$200 million. News Corp intends to commence a tender offer for all of the shares of common stock of Move within 10 business days, followed by a merger to acquire any untendered shares.

“This acquisition will accelerate News Corp’s digital and global expansion and contribute to the transformation of our company, making online real estate a powerful pillar of our portfolio,” said Robert Thomson, Chief Executive of News Corp. “We intend to use our media platforms and compelling content to turbo-charge traffic growth and create the most successful real estate website in the US. We are building on our existing real estate expertise and expect to leverage the potential of Move and its valuable connections with Realtors® and consumers around the country.”

“In addition to boosting Move’s subscription, advertising and software services, this acquisition will give News Corp a significant marketing platform for our media assets, which will benefit from the high-quality geographic data generated by real estate searches,” said Mr. Thomson. “We certainly expect this deal to amount to far more than the sum of the parts.”

“News Corp’s acquisition of Move speaks powerfully to the quality and value of our content, audience and industry relationships,” said Steve Berkowitz, Chief Executive Officer of Move. “We provide people with the information, tools and professional expertise they need to make the best and most informed real estate decisions, and we work to uphold the indispensable role of the professional in the real estate experience. News Corp shares our vision, which is one of the many reasons this combination is such good news for our customers, consumers and the industry as a whole.”

REA Group Chief Executive Tracey Fellows said: “This is a fantastic opportunity for REA Group to invest in a leading player in the largest real estate market in the world. We see strong growth potential for Move, given the size of the US market, the significant proportion of real estate advertising yet to move online, and recent industry consolidation. We believe that our digital real estate know-how, combined with News Corp’s content, distribution and marketing strengths, will be a winning combination for Move and for our shareholders.”

Move has an exclusive, strategic relationship with the National Association of Realtors® (“NAR”), the largest trade organization in the United States, with more than one million members, and NAR has given its consent to the acquisition. Move is focused on providing high ROI for agents and benefits from their invaluable marketing support and high quality listings for vendors and potential purchasers.

“This partnership will help shape the future of real estate,” said National Association of Realtors® President Steve Brown. “News Corp’s ability to reach and engage consumers, combined with realtor.com®’s quality content and the real insights Realtors® provide will transform the current landscape. Working together, Realtors®, Move and News Corp will truly make home happen.”

Move owns ListHub, a digital platform that aggregates and syndicates MLS data to more than 130 online publishers, reaching approximately 900 websites.

The Move audience is highly engaged and transaction ready; over 90% of page views on their websites are on ‘for sale’ properties,3 helping generate the highest conversion rate of qualified leads in the industry4. The connection between agents and customers is strengthened by robust web and mobile-based customer-relationship management offerings to help facilitate transactions. Approximately 60% of traffic for Move websites comes from mobile devices.

For the year ended December 31, 2013, Move reported $227 million in revenues, and $29 million in adjusted EBITDA5, and generated the highest revenue per unique user in the industry.

Move will become an operating business of News Corp and remain headquartered in San Jose, California. The company, started in 1993, has 913 employees.

Some of the expected key benefits of the transaction include:

  • Broadened reach for Move through News Corp’s robust platform including WSJ Digital Network (approximately 500 million average monthly page views6) and News America Marketing (nearly 74 million households)
  • Increased sales and marketing support to drive higher brand awareness and traffic
  • Cross-platform promotion and audience monetization expertise
  • Leverage of News Corp’s and REA’s real estate and digital expertise to drive improved product innovation, consumer engagement and audience growth
  • Boost traffic and digital dwell times with high quality News Corp content

###

In addition to its leading position in Australia, REA’s operations and investments include leading online real estate websites in Italy (casa.it) and Luxembourg (atHome.lu) with presence also in regional France. In Asia, REA operates MyFun.com for the Chinese market and squarefoot.com.hk in Hong Kong and recently acquired a 17.22% stake in iProperty, the leading online real estate advertising business across South East Asia.

Along with its connection to REA, News Corp also has substantial expertise in real estate via its newspaper holdings, including The Wall Street Journal and the New York Post. In 2012, the Journal began publishing Mansion, a successful global luxury real estate section, under the leadership of Mr. Thomson, who was then the Journal’s Managing Editor. News Corp’s UK publications also provide readers with online access to home and apartment listings throughout Great Britain. The Times of London’s lucrative Bricks & Mortar section was also commissioned and overseen by Mr. Thomson while he was Editor of that publication.

“We have great faith in America’s potential and the long-term asset value of housing, which is continuing its recovery and has yet to regain its full potency,” said Mr. Thomson. “It is forecast that the number of Millennial households will increase from 13.3 million in 2013 to 21.6 million in 2018, and they will spend more than $2 trillion on home purchases and rent by 20187. Many will begin their search online and use tools and content on realtor.com®. Buying a home is the most important investment decision any family will make.”

The acquisition is subject to the satisfaction of customary closing conditions, including regulatory approvals and a minimum tender of at least a majority of the outstanding Move shares, and is expected to close by the end of calendar year 2014.

Advisors on the transaction include Goldman Sachs, as financial advisor, and Skadden, Arps, Slate, Meagher and Flom LLP, as legal advisor, for News Corp and Morgan Stanley, as financial advisor, and Cooley LLP, as legal advisor, for Move.

####

Conference Call for Analysts and Media

News Corp will host a call with analysts and media to discuss the proposed acquisition at 8:30 a.m. EDT (Sydney: 10:30 p.m. AEST), September 30, 2014. Reporters are invited to join the call on a listen-only basis.

A live audio webcast of the call will be available via: http://investors.newscorp.com.

The call can also be accessed by dialing:

US Participants: 1800-967-7188
Non-US Participants: 1-719-325-2138
Passcode: 6791228

A replay will be available approximately three hours following the conclusion of the call and for 10 business days thereafter by dialing:

US Participants: 1-888-203-1112
Non-US Participants: 1-719-457-0820
Passcode: 6791228

Forward- Looking Statements

This document contains forward-looking statements based on current expectations or beliefs, as well as a number of assumptions about future events, and these statements are subject to factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Forward-looking statements can often be identified by words such as “anticipates,” “expects,” “intends,” “plans,” “predicts,” “believes,” “seeks,” “estimates,” “may,” “will,” “should,” “would,” “could,” “potential,” “continue,” “ongoing,” similar expressions, and variations or negatives of these words. The reader is cautioned not to place undue reliance on these forward-looking statements, which are not a guarantee of future performance and are subject to a number of uncertainties, risks, assumptions and other factors, many of which are outside the control of News Corporation (“News Corp”) and Move. The forward-looking statements in this document address a variety of subjects including, for example, the expected date of closing of the acquisition and the potential benefits of the proposed acquisition, including integration plans and expected synergies. The following factors, among others, could cause actual results to differ materially from those described in these forward-looking statements: the risk that Move’s business will not be successfully integrated with News Corp’s business; matters arising in connection with the parties’ efforts to comply with and satisfy applicable regulatory approvals and closing conditions relating to the transaction; and other events that could adversely impact the completion of the transaction, including industry or economic conditions outside of our control. In addition, actual results are subject to other risks and uncertainties that relate more broadly to News Corp’s overall business, including those more fully described in News Corp’s filings with the U.S. Securities and Exchange Commission (“SEC”) including its annual report on Form 10-K for the fiscal year ended June 30, 2014, and its quarterly reports filed on Form 10-Q for the current fiscal year, and Move’s overall business and financial condition, including those more fully described in Move’s filings with the SEC including its annual report on Form 10-K for the fiscal year ended December 31, 2013, and its quarterly reports filed on Form 10-Q for the current fiscal year. The forward-looking statements in this document speak only as of this date. We expressly disclaim any current intention to update or revise any forward-looking statements contained in this document to reflect any change of expectations with regard thereto or to reflect any change in events, conditions, or circumstances on which any such forward-looking statement is based, in whole or in part.

Additional Information Regarding the Proposed Transaction

This communication does not constitute an offer to buy or a solicitation of an offer to sell any securities. No tender offer for the shares of Move has commenced at this time. In connection with the proposed transaction, News Corp intends to file tender offer documents with the SEC. Any definitive tender offer documents will be mailed to shareholders of Move. INVESTORS AND SECURITY HOLDERS OF MOVE ARE URGED TO READ THESE AND OTHER DOCUMENTS FILED WITH THE SEC CAREFULLY IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION. Investors and security holders will be able to obtain free copies of these documents (if and when available) and other documents filed with the SEC by News Corp through the SEC website at http://www.sec.gov or through the News Corp website at http://investors.newscorp.com.

About News Corp

News Corp (NASDAQ: NWS, NWSA; ASX: NWS, NWSLV) is a global, diversified media and information services company focused on creating and distributing authoritative and engaging content to consumers throughout the world. The company comprises businesses across a range of media, including: news and information services, cable network programming in Australia, digital real estate services, book publishing, digital education, and pay-TV distribution in Australia. Headquartered in New York, the activities of News Corp are conducted primarily in the United States, Australia, and the United Kingdom. More information: http://www.newscorp.com.

About Move, Inc.

Move, Inc. (NASDAQ:MOVE), a leading provider of online real estate services, operates realtor.com®, which connects people to the essential, accurate information needed to identify their perfect home and to the REALTORS® whose expertise guides consumers through buying and selling. As the official website for the National Association of REALTORS®, realtor.com® empowers consumers to make smart home buying, selling and renting decisions by leveraging its direct, real-time connections with more than 800 multiple listing services (MLS) via all types of computers, tablets and smart telephones. Realtor.com® is where home happens. Move is based in the heart of the Silicon Valley — San Jose, CA. REALTOR® and REALTOR.COM® are trademarks of the National Association of REALTORS® and are used with its permission.

About REA Group

REA Group Limited ACN 068 349 066 (ASX:REA) is a leading digital advertising business specialising in property. REA Group operates Australia’s No.1 residential and commercial property websites, realestate.com.au and realcommercial.com.au, as well as the market-leading Italian property site, casa.it, squarefoot.com.hk in Hong Kong, myfun.com in China and other property sites and apps across Europe. www.rea-group.com.

1 Move, Inc. Internal data (August 2014).
2 Borrell Associates (August 27, 2014).
3 Move, Inc. Internal data (August 2014).
4 PAA Research Independent Study.
5 Adjusted EBITDA excludes stock-based compensation.
6 Adobe Omniture, for the year ended June 30, 2014.
7 2013 Demand Institute Housing & Community Survey.

Tuesday, September 30th, 2014 Uncategorized Comments Off on (MOVE) News Corp To Acquire Move, Inc.

(MCIG) Forms Colorado Subsidiary mCig CBD Technologies, LLC.

BELLEVUE, Wash., Sept. 30, 2014  — mCig®, Inc. (OTCQB:MCIG) (“mCig”), a technology company that owns, manufactures, and distributes the mCig®, VitaCig®, and Vapolution products, is pleased to announce that the Company has formed a 100% owned subsidiary: mCig CBD Technologies, LLC. in the state of Colorado for the purpose of designing and manufacturing a new line of products that will leverage the VitaCig technology for delivery of Cannabis plant derivatives. The Cannabis plant is a unique source of over 70 cannabinoid molecules of which only THC is known to cause psychoactive effects. Cannabinoids such as Cannabidiol (CBD) have shown to have positive medicinal effects on various hard-to-treat diseases such as epilepsy.

This new line of products will be named: “mCig+” and will include pre-packaged devices that look similar to the company’s VitaCig® line of products. These products will only be sold to licensed distributors and dispensaries in jurisdictions around the world where the consumption of Cannabis and Cannabidiol is permitted.

The company will be building on nearly a decade of experience in bringing vaporization products to market such as the Vapolution, mCig®, and VitaCig®. In the last year alone mCig, Inc. has launched 3 consumer products that have touched the lives of nearly 30,000 customers worldwide.

mCig CBD Technologies, LLC. will remain 100% owned by mCig, Inc. following the proposed spinoff, dividend, and IPO of VitaCig® Inc.

“We are extremely excited to be entering yet another frontier market. We believe to have identified an opportunity to apply our experience in mobile vaporization in applications for the delivery of cannabis plant derivatives and molecules. There is currently a massive effort underway globally by biotechnology companies and scientific research institutions to explore and understand the ultimate potential of the cannabis plant. This push has already yielded some important results such as those witnessed for Dravet syndrome, a rare form of intractable epilepsy. We believe that our products and brand recognition provide us with a commercial opportunity to manufacture and distribute pre-packaged devices with various cannabis plant molecules such as CBD, CBC, THC, CBG, CBN, THCV, CBDV, CBDA, and many others. We have already completed an initial round of testing utilizing CBD and THC that have successfully administered these molecules utilizing our vaporization technology,” said Paul Rosenberg, CEO of mCig, Inc.

Other General Updates

The company continues to make substantial progress in all of its business segments and will be providing additional updates as they are warranted. The VitaCig amended S1 has been filed with the Securities and Exchange Commission and the company hopes this will be the final amendment paving the way for the Spinoff, IPO, and Dividend of VitaCig®, Inc.

About mCig, Inc.

mCig, Inc. (OTCQB:MCIG) is a technology company focused on two long-term secular trends sweeping the globe: (1) The decriminalization and legalization of marijuana for medicinal or recreational purposes (2) The adoption of electronic vaporizing cigarettes (commonly known as “eCigs”) by the world’s 1.2 Billion smokers. The company manufactures and retails the mCig® – the world’s most affordable vaporizer priced at only $10. Designed in the USA – the mCig® provides a superior smoking experience by heating plant material, waxes, and oils delivering a smoother inhalation experience. The company also owns Vapolution, Inc. which manufactures and retails home-use vaporizers such as the Vapolution 2.0. Through its wholly owned subsidiary, VitaCig, Inc. the company manufactures and retails the VitaCig®, a $5 nicotine-free eCig that delivers a water-vapor mixed with vitamins and natural flavors. See more at: http://www.mCig.org/, www.Vapolution.com, and www.VitaCig.org

The company believes that a well regulated marijuana industry is emerging as more states follow the lead of Washington and Colorado in legalizing marijuana. A similar trend is developing within the eCig industry following the first acquisition of an electronic cigarette brand (Blucigs) by a traditional tobacco company Lorillard Inc. for $135 million followed by another acquisition in February 2014 by Altria Group Inc. of Green Smoke for $150 million. Wells Fargo analyst Bonnie Herzog estimates that eCig sales may rise from $1 Billion in 2013 to $10 billion over the next three years.

mCig, Inc. (OTCQB:MCIG) has positioned itself as a first mover at the intersection of these two trends and hopes to create shareholder value by making the mCig® one of the leading choices for electronic consumption of plant material. – See more at: http://www.mcig.org/investors/investor-opportunity-subpage/

Safe Harbor Statement

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company’s ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company’s products and technology; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, and future product commercialization; and the Company’s business, research, product development, regulatory approval, marketing and distribution plans and strategies.

CONTACT: Paul Rosenberg
         CEO
         1(425)652-5946
Tuesday, September 30th, 2014 Uncategorized Comments Off on (MCIG) Forms Colorado Subsidiary mCig CBD Technologies, LLC.

(GYSN) Oct. 17 Canadian Kickoff on The Shopping Channel of Its Anti-Aging Skin Care

Greyson says it’s a clear sign company’s moving vigorously forward after death of its legendary CEO as he had wanted

COCONUT CREEK, Fla., Sept. 30, 2014  — Greyson International, Inc. (OTC Pink Sheets: GYSN) announced today the long-awaited TV launch of the Greyson Skin Care product line, with the patented Trilexon® topical delivery system, will be Oct. 17. It will receive four separate thirty (30) minute live TV airings that day on one of the leading interactive multi-channel retailers in North America, The Shopping Channel of Canada (tsc.ca), just as the company’s late CEO Harvey Tauman had planned prior to his death in July.

The well-known TV spokesperson Andrea Tilis will present the Greyson Skin Care kit on Oct. 17 at 9:30am, 1:30pm, 4:30pm and 8:30pm on The Shopping Channel seen throughout Canada. (All times are Eastern.)

“We’re excited to be carrying out the first of many things my father had planned to do as he believed so passionately.  Our skin care products with Trilexon are infinitely more effective and longer lasting than any other cosmetics,” said his son, Richard Tauman, Director of Operations of the company, now headed by Mukesh Prasad.  The company was founded by Harvey Tauman, who had held some of the most awesome cosmetics sales records in the history of TV home shopping.

Our technology supports the skin’s barrier layer and maintains a specific pH level on the skin to reduce moisture evaporation, thus promoting the ingredient penetration. Also, Trilexon’s® extended delivery of ingredients into the skin lasts longer.

In independent third party laboratory tests, performed by Peter T. Pugliese, M.D. and Zoe Diana Draelos, M.D., Trilexon® proved to deliver active ingredients at a consistent rate for extended periods. Unlike most emulsion systems once applied on the skin, it continues to emulsify and break down the barrier layer, the Greyson’s Trilexon® Delivery System stops emulsifying the essential oils and keeps the barrier layer intact.

About Greyson International, Inc.

Greyson’s patented Trilexon® delivery system, in addition to cosmetic applications, may have benefits in the medical field where it’s important to deliver active ingredients. Trilexon® is a registered trademark of Greyson International Inc. Information is available http://greysonintl.com and join the Greyson International’s Facebook page http://www.facebook.com/GreysonInternationalInc.

This release contains information about management’s view of future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with company’s financial condition, ability to sell its products and compete with competitors.  Please review other factors that may affect our future results on any current or future documents we file periodically with Securities & Exchange Commission.

Contacts:
Greyson International, Inc., Mukesh Prasad 954-482-0497, President, mukesh@greysonintl.com.
Media: Adrienne Mazzone 561-750-9800 x2270; amazzone@transmediagroup.com.

Tuesday, September 30th, 2014 Uncategorized Comments Off on (GYSN) Oct. 17 Canadian Kickoff on The Shopping Channel of Its Anti-Aging Skin Care

(MITD) Commences Treatment of Patients in Phase 3 FDA Clinical Trial With SERRG

Total of 660 Patients Expected to Be Treated Over a 12 Month Period

SAVANNAH, GA–(Sep 30, 2014) – MIT Holding, Inc. (OTCQB: MITD) announces the intake of patients for a FDA clinical trial. MITD through its affiliates are acting as sub-investigators for Melinta Theraputics, the primary investigator in the study managed by SERRG Savannah. MIT Holding, Inc. will generate revenues throughout this 12-month study.

Walter Drakeford, President of MIT Holding stated, “We are pleased to open this new revenue stream as a result of being selected by SERRG as a sub-investigator facility. This is evidence that our corporate re-organization and business model is capable of opening and generating new income streams through our partner affiliation programs. The facility and staff underwent intense scrutiny and was selected after a rigorous evaluation by SERRG and the State of GA. The Company is excited to continue pursuing other similar opportunities in this lucrative and specialized field.”

Patients will receive a two to four hour infusion in a blind study. The trial will last for twelve months with approximately six hundred and sixty patients treated in the entire trial at multiple facilities throughout the United States, under various sub-investigators.

For further information and news about the Company click the following links:

Click here for recent news on MITD.
Click here for study updates ClinicalTrials.gov
Click here for current SEC filings for MITD.
Click here for ProActive Capital Group.

About MIT Holding, Inc.:
Through its affiliations, MITD distributes wholesale pharmaceuticals, licensed to administer intravenous infusions, and operates ambulatory centers where therapies are administered, and sells and rents home medical equipment. MITD has initiated government contacts to obtain the necessary approvals to import pharmaceutical products into the Americas. MIT’Ds domestic wholesale pharmaceutical distribution is conducted through its contracts and affiliations, which sells pharmaceuticals to end-users and other wholesalers.

For more information, contact Mr. William Nalley, Orsay Groupe, info@orsaygroupe.com, phone 305-515-8077 and/or visit http://www.mitholdingsinc.com/home-2.

This news release contains “forward-looking statements” as defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements regarding beliefs, plans, expectations or intentions contain reasonable expectations, but there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate.

Contact:
William Nalley
305-515-8077
Email Contact

Tuesday, September 30th, 2014 Uncategorized Comments Off on (MITD) Commences Treatment of Patients in Phase 3 FDA Clinical Trial With SERRG

(HRDND) Looks To Power the Cannabis Industry

DC Brands Looks to Power the Cannabis Industry

WHITEFISH, MT / September 30, 2014 / The U.S. cannabis industry is expected to reach $2.6 billion in 2014 compared to $1.5 billion last year, according to ArcView Market Research, driven by the legalization of medical marijuana in 23 states and Washington D.C., as well as the potential for adult-use legalization in Alaska and Oregon. With these rapid growth rates and catalysts, investors have been increasingly drawn to the industry.

In Canada, the Marihuana for Medical Purposes Regulations (“MMPR”) framework has created a clear pathway for companies like Tweed Marijuana Inc. [TWMJF] (TSX-V: TWD) to operate legally. The U.S. has taken a different approach where cannabis remains illegal on a federal level, but certain states have legalized the production and use of the substance.

In this article, we’ll take a look at DC Brands International Inc. [HRDND] * and its plans to become a leading provider of consulting services and financing within the cannabis industry. (* after October 6th, 2014 the ticker symbol will revert to HRDN)

CannabisFN Executive Interview | DC Brands (HRDN) from TDM Financial on Vimeo.

U.S. Exposure to the Cannabis Industry

DC Brands International has taken a unique approach to the U.S. cannabis industry, which provides investors with direct exposure and limited risk. By providing consulting and financing services, the company operates under variable rate contracts that grow with the revenue of their clients. These dynamics provide investors with exposure to the market without the risk of direct ownership.

In early September, the company announced a binding letter of intent to acquire Colorado-based Lotus MMJ Consulting LLC. Founders Erik Santus and Hung Nguyen are also involved with Lotus Medical LLC, which operates a medical marijuana dispensary in Denver, Colorado. The team’s experience running a live dispensary sets it apart from many competitors in the cannabis consulting space.

“I believe that partnering with executives who have started and grown one of the premier Colorado MMJ dispensary operations and then started their consulting business because people across the country began reaching out to them, will be invaluable to the success of this venture,” said DC Brands International CEO and CFO Bob Armstrong in the press release announcing the deal.

Near-term Cash Flow Potential

DC Brands International reported revenue of $40,000, during the quarter ended June 30, 2014, through its 80% ownership interest in DC Brands Green Investors LLC. With the model proven by early revenue, the company believes that its Lotus MMJ Consulting LLC agreement will scale the model to new levels over the coming quarters, potentially bringing the firm closer to a breakeven point.

“We are very pleased to announce revenues from our new business direction,” said Mr. Armstrong in the July press release. “This is the first step in achieving anticipated positive cash flow and continuing to provide value to our debt holders and shareholders. After attending WeedStock in Denver earlier this week, I am very excited about our business model and the direction of the marijuana industry.”

Through its DC Brands Green Investors LLC agreement alone, management anticipates generating between $1.5 million and $2.75 million over the first three years through a 5% interest in Venture Investment Partners LLC’s EBITDA. The agreement with Lotus MMJ Consulting LLC could significantly expand these figures given its existing contract with a Denver dispensary and the team’s experience.

Looking Ahead

DC Brands International has a market capitalization of less than $60,000, according to OTC Markets, as it remains in its early stages. With the potential for over $1 million in 2015 revenue and cash flow positivity, investors may want to take a closer look at the company as a way to gain exposure to the U.S. cannabis industry without taking on a lot of the regulatory risks associated with other ventures.

In particular, investors in the medical marijuana space, including companies like Medical Marijuana Inc. [MJNA], or ancillary product providers, like GreenGro Technologies Inc. [GRNH], may want to take a closer look at the company as a way to diversify, particularly given that its contracts provide a virtual revenue interest in active dispensary operations.

For more information, see the following resources:

Lotus Consulting Website

Disclaimer: Except for the historical information presented herein, matters discussed in this release contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/

Tuesday, September 30th, 2014 Uncategorized Comments Off on (HRDND) Looks To Power the Cannabis Industry

(FLPC) Secures Refining Capacity in the United States

Pathways of Progress Announcement

Reno, NV, Sept. 29, 2014  — First Liberty Power Corp. (FLPC: OTC Pink), a diversified exploration, development and junior mining company focused on strategic minerals for America’s future, today announced the completion of a Letter of Intent (“LOI”) to acquire a 50% operational interest in a central Nevada processing facility, known as the Liberty Precious Metals Processing Facility (the “Liberty Mill”).

First Liberty Power CEO, Don Nicholson, provided details of this significant FLPC development.  “After extensive negotiations, First Liberty Power has entered into a binding LOI for a definitive share purchase agreement (“SPA”) to acquire 50% of the issued and outstanding shares of Coronet Metals US Inc. (Coronet US) from Coronet Metals Inc.  Coronet US currently holds the lease to operate and has expended a capital investment of $2.1 million in the Liberty Mill, which is located on 40-acres of private land in Amargosa Valley, Nevada, approximately two hours north‐west of Las Vegas.  The SPA is to be concluded before Monday, October 6th.”  http://www.firstlibertypower.com/investors/filings/

The Liberty Mill is a gravity separation operation that is also permitted to use cyanide for leaching material that is not recoverable through that separation process. Currently, the operation is fully permitted to process up to 50 tons of feed material per day from Nevada, as well as out-of-state supply.  Identified assets of the Liberty operation include a feed storage containment area, feed hopper, Deister table, wet magnetic separation, ball mill, chemical leaching circuit, filtration, Merrill-Crowe precious metals precipitation, refinery, and two separate water recovery/recycle systems.

CEO Nicholson noted the impact of the joint mill venture relative to the Company’s broad-based advances and objectives.  “Over the last year, the FLPC management team has increased the Company’s mineral properties to more than 1200 acres, including a gold (AG) mineral exploration operation on the Rose Creek Properties with near-term expectations of gold production to improve the FLPC balance sheet. In obtaining this well-established Liberty Mill operation, FLPC has now taken steps that immediately enhances the prospects of the Company’s mining business by providing a near-term solution to refining constraints.  Moreover, this joint venture advances another FLPC objective of having a facility which, with relatively straight-forward enhancements, will be able to host a dedicated operational line to produce high grade stibnite (antimony) concentrate sourced from our properties.”

In acknowledging the significance of the Liberty Mill acquisition, First Liberty Power COO, Jimmy Trikeriotis, detailed the operational impact.  “Having access to the Liberty Mill operation greatly expands FLPC’s short and mid-term options for both the refining of gold ore concentrates and stibnite as well as other ores.  This opportunity fits in ideally with the Company’s active development plans for milling and refining capacity in Winnemucca, as it allows for the tailoring of the respective facilities for different ore types and processing methods, and optimizes the transportation logistics of varying ore and concentrate sources.”

First Liberty Power will continue to use Pathways of Progress announcements to make public Company details and operational advancements.  www.firstlibertypower.com

ABOUT FIRST LIBERTY POWER CORPORATION (OTC Pink: FLPC):  First Liberty Power Corporation is a diversified exploration, development and mining company focused on bringing to market strategic minerals for America’s Future.  First Liberty Power’s corporate philosophy is founded on a methodology designed to drive the company’s exploration, development and mining operations, while ensuring safety, environmental integrity, and good governance. Included in that philosophy is Pathways of Progress (POP), a platform used to inform shareholders, investors and mining partners of FLPC news and advancements through open and transparent communication.  First Liberty is focused on exploring and developing antimony and other strategic metal projects and properties.

www.firstlibertypower.com            www.facebook.com/FirstLibertyPower           https://twitter.com/FirstLibertyOTC

ABOUT CORONET METALS USA :  Coronet Metals Inc. (TSXV:CRF, OTCQX:CORMF, FWB: 2CM) is a junior gold exploration and development company focused on building a substantial junior gold production and exploration company by acquiring advanced, near production, low cost assets with upside potential in the Americas and is well positioned to generate value for its shareholders.  The Company is advancing the Liberty Precious Metals Testing in Nevada to production over the next year. Liberty commenced production in 2013 and is permitted to commercially process up to 50 tons per day of material to recover precious metals from feed materials such as mine ores and flotation/gravity concentrates. Liberty offers near-term cash flow and significant upside potential. It is located two hours north-west of Las Vegas, Nevada on 40 acres of private land. In February 2013, Coronet entered into a 24-month Lease with the option to purchase the facility.  http://www.coronetmetals.com/

Notice Regarding Forward-Looking Statements

This current report contains “forward-looking statements,” as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future plans of the company, the prospects for our mineral properties, and our ability to raise necessary working capital. Actual results could differ from those projected in any forward-looking statements due to numerous factors, including the inherent uncertainties associated with mineral exploration and difficulties associated with obtaining financing on acceptable terms. We are not in control of metals prices and these could vary to make development uneconomic. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that they will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our most recent annual report for our last fiscal year, our quarterly reports, and other periodic reports filed from time-to-time with the SEC.

CONTACT: For more information contact:
         Robert Reynolds (800)709-1196
         ir@firstlibertypower.com

         Thomas Dean (646)396-9615
         Murdock Capital Partners
         tdean@murdockcapital.com
Monday, September 29th, 2014 Uncategorized Comments Off on (FLPC) Secures Refining Capacity in the United States

(BAGL) Enters Agreement to be Acquired by JAB Holding for $20.25/Share, Cash

Einstein Noah Restaurant Group, Inc. (NASDAQ:BAGL), a leader in the fast-casual segment of the restaurant industry operating under the Einstein Bros.® Bagels, Noah’s New York Bagels®, and Manhattan Bagel® brands and JAB Holding Company (“JAB”) today announced a definitive agreement under which an affiliate of JAB will acquire Einstein Noah Restaurant Group for $20.25 per share in cash, or a total diluted equity value of approximately $374 million. The agreement, which has been unanimously approved by Einstein Noah Restaurant Group’s directors, represents a premium of approximately 47 percent over Einstein Noah Restaurant Group’s 30-day average trading price.

“Einstein Noah Restaurant Group has a great collection of brands that reflect JAB’s long-term investment philosophy and we see significant opportunity for growth,” said Olivier Goudet, Partner and CEO of JAB. “We welcome Einstein Noah Restaurant Group and its employees to the JAB family, and we are excited to be a part of the next chapter of its growth.”

“Greenlight supports this transaction, which we believe delivers significant value to Einstein Noah Restaurant Group stockholders and is a win-win for all parties,” said David Einhorn, founder and president of Greenlight Capital, Einstein Noah Restaurant Group’s largest stockholder. “For more than a decade, we have worked closely with the Einstein Noah Restaurant Group to execute a turnaround plan, reducing debt and expanding its store footprint. JAB is an experienced firm that will lead Einstein Noah Restaurant Group into its next phase of growth.”

At the close of the transaction, Einstein Noah Restaurant Group will maintain its headquarters in Lakewood, Colorado and will continue to operate as a standalone business in the JAB portfolio, consistent with the firm’s investment practice. Michael Tattersfield, Chief Executive Officer of Caribou Coffee Company, Inc., another JAB portfolio company, will serve as Chairman of the Board.

“I am looking forward to working with the Einstein Noah Restaurant Group’s talented executive team. Having worked in and around the food industry for many years, I have long admired the Einstein Noah Restaurant Group’s strong market position and growth potential, and I am looking forward to contributing to the company’s continued success,” said Mr. Tattersfield.

“Through this transaction with JAB, which has a long and distinguished track record of investing in premium consumer companies, we will not only realize significant immediate value for our stockholders, but will continue to revitalize our brand, enhance our nationwide footprint and solidify our position as the leader in the fresh-baked bagels industry,” said Nelson Heumann, Chairman of the Board of Einstein Noah Restaurant Group. “Over the past few years, our dedicated employees have helped enhance our strong and growing brand leadership, and with JAB’s backing, we expect to build upon our success and position as a category leader.”

Under the terms of the merger agreement, an affiliate of JAB will promptly commence a tender offer to acquire all of the outstanding shares of Einstein Noah Restaurant Group’s common stock at a price of $20.25 per share in cash. Greenlight Capital, Einstein Noah Restaurant Group’s largest stockholder with more than 35% of the outstanding common shares, has agreed to tender its shares in support of the transaction. Following the successful completion of the tender offer, JAB will acquire all remaining shares not tendered in the offer through a second-step merger at the same price as in the tender offer.

The consummation of the tender offer is subject to various conditions, including a minimum tender of at least a majority of Einstein Noah Restaurant Group’s outstanding shares on a fully diluted basis, the expiration or termination of the waiting periods under applicable competition laws, and other customary conditions. The tender offer is not subject to a financing condition.

BDT Capital Partners, a Chicago-based merchant bank that provides long-term private capital solutions to closely held companies, is a minority investor in this transaction alongside JAB. In addition to BDTCP’s capital investment, BDT & Company, LLC, served as a financial co-advisor to JAB with Citigroup Global Markets Inc. Skadden, Arps, Slate, Meagher & Flom LLP is acting as legal advisor to JAB in this transaction. Stifel is serving as financial advisor to Einstein Noah Restaurant Group in connection with this transaction and Alston & Bird LLP is acting as Einstein Noah Restaurant Group’s legal advisor.

About Einstein Noah Restaurant Group

Einstein Noah Restaurant Group, Inc. is a leading company in the quick-casual segment of the restaurant industry that operates, franchises and licenses locations under the Einstein Bros.®, Noah’s New York Bagels® and Manhattan Bagel® brands. The Company’s retail system consists of more than 855 restaurants in 42 states and the District of Columbia. It also operates a dough production facility. The Company’s stock is traded on the NASDAQ under the symbol BAGL. Visit www.einsteinnoah.com for additional information.

About JAB Holding Company

JAB Holding Company and affiliated companies is a privately held group focused on long-term investments in companies with premium brands in the Fast Moving Consumer Goods category. JAB Holding Company’s portfolio includes a majority stake in Coty Inc., a global leader in beauty, a majority stake in Peet’s Coffee & Tea Inc., a premier specialty coffee and tea company, a majority stake in Caribou Coffee Company, a specialty retailer of high-quality premium coffee products, a majority stake in D.E Master Blenders 1753 N.V., an international coffee and tea company, and a minority stake in Reckitt Benckiser Group PLC, a global leader in health, hygiene and home products. JAB also owns luxury leather goods companies including Jimmy Choo, Bally and Belstaff. The assets of the group are overseen by its three senior partners, Peter Harf, Bart Becht and Olivier Goudet.

About BDT Capital Partners

BDT Capital Partners provides family-owned and entrepreneurially led companies with long-term capital. Based in Chicago, the firm manages $10 billion across its investment funds and has an investor base with the ability to co-invest significant additional capital. Its affiliate, BDT & Company, is a merchant bank that works with family and founder-led businesses to pursue their long-term strategic and financial objectives. BDT & Company provides solutions-based advice and access to an extensive network of world-class closely held businesses.

Additional Information and Where to Find It

The tender offer described in this document has not yet commenced. This announcement is neither an offer to purchase nor a solicitation of an offer to sell shares of Einstein Noah Restaurant Group. At the time the offer is commenced, an affiliate of JAB will file a Tender Offer Statement on Schedule TO with the Securities and Exchange Commission (the “SEC”), and Einstein Noah Restaurant Group will file a Solicitation/Recommendation Statement on Schedule 14D-9 with respect to the offer. Einstein Noah Restaurant Group stockholders and other investors are urged to read the tender offer materials (including an Offer to Purchase, a related Letter of Transmittal and certain other offer documents) and the Solicitation/Recommendation Statement because they will contain important information which should be read carefully before any decision is made with respect to the tender offer.

The Offer to Purchase, the related Letter of Transmittal and certain other offer documents, as well as the Solicitation/Recommendation Statement, will be made available to all stockholders of Einstein Noah Restaurant Group at no expense to them. The Tender Offer Statement and the Solicitation/Recommendation Statement will be made available for free at the SEC’s web site at www.sec.gov. Free copies of these materials and certain other offering documents will be made available by the information agent for the offer.

In addition to the Solicitation/Recommendation Statement, Einstein Noah Restaurant Group files annual, quarterly and special reports, proxy statements and other information with the SEC. You may read and copy any reports, statements or other information filed by Einstein Noah Restaurant Group at the SEC public reference room at 100 F Street, N.E., Washington, D.C. 20549. Please call the SEC at 1-800-SEC-0330 for further information on the public reference room. Einstein Noah Restaurant Group’s filings with the SEC are also available to the public from commercial document-retrieval services and at the website maintained by the SEC at www.sec.gov.

Forward-Looking Statements

This communication contains forward-looking statements that are not historical facts and are subject to risks and uncertainties that could cause actual results to differ materially from those described. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. Forward-looking statements often use words such as “anticipate,” “target,” “assume,” “expect,” “estimate,” “intend,” “plan,” “goal,” “believe,” “hope,” “aim,” “continue,” “will,” “may,” “would,” “could,” “likely,” or “should” or other words of similar meaning or the negative thereof. Forward-looking statements in this communication include statements regarding the anticipated benefits of the transaction; statements regarding the anticipated timing of filings and approvals relating to the transaction; statements regarding the expected timing of the completion of the transaction; and any statements of assumptions underlying any of the foregoing. All forward-looking statements are based largely on current expectations and beliefs concerning future events, approvals and transactions that are subject to substantial risks and uncertainties. Factors that may cause or contribute to the actual results or outcomes being different from those contemplated by forward-looking statements include: risks and uncertainties associated with the tender offer, including uncertainties as to the timing of the tender offer and merger, uncertainties as to how many of the Einstein Noah Restaurant Group’s stockholder will tender their shares in the offer, the risk that competing offers will be made, and the possibility that various closing conditions for the transaction may not be satisfied or waived. Other factors that may cause the Einstein Noah Restaurant Group’s actual results to differ materially from those expressed or implied in the forward-looking statements are discussed in the Einstein Noah Restaurant Group’s filings with the SEC, including in its periodic reports filed on Form 10-K and Form 10-Q with the SEC. Copies of the Einstein Noah Restaurant Group’s filings with the SEC may be obtained at the “Financial and Media – Investor Relations” section of the Einstein Noah Restaurant Group’s website at www.einsteinnoah.com. The forward-looking statements made in this communication are made only as of the date of this communication, and the Einstein Noah Restaurant Group undertakes no obligation to update them to reflect subsequent events or circumstances.

Monday, September 29th, 2014 Uncategorized Comments Off on (BAGL) Enters Agreement to be Acquired by JAB Holding for $20.25/Share, Cash

(XCLL) Announces Acquisition of Online Lottery Business in China

Further Leverages Established Online Business Platform

Completion of Move to New Office HQ

PALO ALTO, CA–(Sep 29, 2014) – XcelMobility, Inc. (OTCQB: XCLL) (OTCBB: XCLL) (“Xcel” or the “Company”), a leading mobile internet application development and marketing company, today announced that it has entered into an agreement to acquire Silver Creek Digital’s Online Sports Lottery Business Unit, including its proven products, licenses, industry relationships and talented employees.

“We’re very excited about the growth opportunities that can quickly develop once we incorporate Silver Creek’s online sports lottery business within our existing online mobile platform,” said Ronald Strauss, Executive Chairman of XcelMobility. “Silver Creek has been using our cloud network in China for over a year and we have already witnessed the growth that can be achieved by combining our resources. We are confident that their proven success to date and established key relationships in China will drive our ability to strongly penetrate the very new and fast-growing online lottery business in China. Together, XcelMobility can move forward as an even stronger online player in China and can quickly become a leader in the online lottery market in China that is growing at over 40% per year.”

The Chinese lottery market has experienced strong growth in recent years as a result of positive macro trends in China, such as robust economic growth, increases in disposable income and a more positive shift in public perception towards the lottery business. Total lottery sales in China is projected to be $61 billion and $73.3 billion in 2014 and 2015, respectively, representing a 21.5% and 20.3% increase in 2014 and 2015 from their respective preceding years, according to an iResearch Report. The iResearch Report projected online sales amount for sports lottery products to be $2.2 billion and $3.2 billion in 2014 and 2015, respectively, representing 47.3% and 44.8% increase from the respective preceding years.

Specific financial terms of the transaction are undisclosed. The transaction is subject to various standard closing conditions and is expected to close within 30 days.

XcelMobility has also announced that it has completed the move to its new headquarters in Palo Alto, CA. The new address is 2225 East Bayshore Rd., Suite 200, Palo Alto, CA 94303. Phone: (650) 320-1728.

About XcelMobility, Inc.
XcelMobility is a leading developer and marketer of mobile internet products and services, specifically focused on China’s burgeoning mobile market of well over 1 Billion Users. The Company continues to grow through acquisition, including the recent online lottery business.

For more information email info@xcelmobility.com or visit: www.xcelmobility.com and https://www.facebook.com/pages/Xcelmobility-Inc/275827129230531

Notice Regarding Forward-Looking Statements
This news release contains “forward-looking statements” as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development of new business opportunities, zero operational impact and projected costs, future operations, revenue, profits, gross margins and results of operations. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

Investor Relations Contact:

Stanley Wunderlich
Consulting for Strategic Growth 1 Ltd.
Tel: 800-625-2236 ext. 7770
Email: info@cfsg1.com

Monday, September 29th, 2014 Uncategorized Comments Off on (XCLL) Announces Acquisition of Online Lottery Business in China

(MKHD) Announces a Definitive Agreement to Acquire Civergy Inc.

NEW YORK, NY–(September 29, 2014) – Mount Knowledge Holdings, Inc. (OTCQB: MKHD), a software development and sales company focused on providing innovative technology solutions announced today that it has entered into a definitive agreement to acquire 100% of Civergy, Inc., a national leader in smart grid technologies and cyber-security, in a share exchange agreement pursuant to which its shareholders will become the majority owners of the MKHD.

Civergy generated more than $35 million in revenue (unaudited) in 2013. Through its operating subsidiaries, Civergy is a national leader in smart grid technologies and cyber-security products and services to clients including U.S. Federal Government agencies, State, local and Tribal government and commercial clients. For the past 18 years, the Civergy group of companies has led advanced transportation research, strategic program development and implementation, environmental analysis, IT computer support services, grants management, and engineering under contracts with the U.S. Department of Energy and Department of Defense, among dozens of other clients.

Headquartered in Englewood, Colorado, Civergy’s team of approximately 130 employees delivers innovative technical and management services through its 3 divisions: New West Technologies, which was founded in 1996 and provides clean, smart and reliable energy solutions and is a 5 time winner of the Inc. 500/5000 fastest growing private companies in America; PriMETRIX, which serves U.S. federal government contractor firms with contract procurement, compliance and growth services; and Cybergy Labs, an award-winning developer of specialized cyber-security software applications including “SmartFile,” providing real-time document intelligence by inserting a new layer of security and reporting into sensitive files. (See: http://www.bioncorp.com)

“We’re excited and privileged to be acquiring a company of such unique caliber that has led its field for almost two decades in the development, advisory and protection of critical infrastructure for a broad array of government and commercial clients,” stated Jason Sawyer of Access Alternative Group, the lead investor in Mount Knowledge.

Mark Gray, Chairman and CEO of Civergy said, “Today marks a major milestone as Civergy merges with Mount Knowledge to grow our combined family of technology companies. With our overall proven track record in software development and contract services for government and tier-one commercial clients, combined with a management team of highly decorated and experienced professionals, we stand to create a strong partnership that we’ll all be honored to be a part of.”

Civergy engaged Source Capital Group, Inc. to act as M&A advisor on the transaction, with Chardan Capital Markets, LLC acting as lead placement agent and financial advisor.

The transaction is anticipated to close on October 1, 2014. For more information, please visit www.mkhd.net or www.civergy.com.

Forward-Looking Safe Harbor Statement:

This press release, other than historical information, contains forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, and are subject to risks and uncertainties. In some cases, you may identify forward-looking statements by words such as “may,” “should,” “plan,” “intend,” “potential,” “continue,” “believe,” “expect,” “predict,” “anticipate” and “estimate,” the negative of these words or other comparable words. These statements are only predictions. One should not place undue reliance on these forward-looking statements. The forward-looking statements are qualified by their terms and/or important factors, many of which are outside the Company’s control, involve a number of risks, uncertainties and other factors that could cause actual results and events to differ materially from the statements made. The forward-looking statements are based on the Company’s beliefs, assumptions and expectations about the Company’s future performance, taking into account information currently available to the Company. The Company will update this forward-looking information only to the extent required under applicable securities laws. Neither the Company nor any other person assumes responsibility for the accuracy or completeness of these forward-looking statements. For a discussion of these risks and uncertainties, please see our filings with the Securities and Exchange Commission. Our public filings with the Commission are available from commercial document retrieval services and at the website maintained by the Commission at http://www.sec.gov.

James D. Beatty
CEO
Mount Knowledge Holdings, Inc.
228 Park Ave. S #56101
New York, NY 10003-1502
admin@mkhd.net
(917) 289-0944

Mark Gray
CEO
Civergy Inc.
1800 Corporate Drive, Suite 800
Landover, MD 20785
mgray@civergy.com
(404) 543-2230

George Kaufman
Chardan Capital Markets, LLC
17 State Street, Suite 1600
New York, NY 10013
gkaufman@chardancm.com
(646) 465-9015

Vik Grover
CFA
Source Capital Group, Inc.
276 Post Road West
Westport, CT 06880
vgrover@sourcegrp.com
(212) 731-4806

Monday, September 29th, 2014 Uncategorized Comments Off on (MKHD) Announces a Definitive Agreement to Acquire Civergy Inc.

(AMBI) Daiichi Sankyo to Acquire Ambit Biosciences

Lead Compound, Quizartinib, Will Further Build Daiichi Sankyo Oncology Pipeline

TOKYO and SAN DIEGO, Sept. 29, 2014  — Daiichi Sankyo Company, Ltd. (hereinafter Daiichi Sankyo) (TSE: 4568) and Ambit Biosciences (NASDAQ: AMBI), jointly announced today that they have entered into a definitive merger agreement under which Daiichi Sankyo will acquire all of the outstanding common stock of Ambit Biosciences for $15 per share in cash through a tender offer followed by a merger with a subsidiary of Daiichi Sankyo, or approximately $315 million on a fully diluted basis.  In addition to the upfront cash payment, each Ambit Biosciences stockholder will receive one Contingent Value Right (CVR), entitling the holder to receive an additional cash payment of up to $4.50 for each share they own if certain commercialization related milestones are achieved. The total transaction is valued at up to $410 million on a fully diluted basis.

Ambit Biosciences, a publicly traded, biopharmaceutical company, is focused on the discovery and development of medicines to treat unmet medical needs in oncology, autoimmune and inflammatory diseases by inhibiting enzymes that are important drivers for those diseases.  The lead Ambit Biosciences drug candidate, quizartinib, is currently in phase 3 clinical trials among patients with acute myeloid leukemia (AML), who express a genetic mutation in FLT3 and who are refractory to or relapsed after first-line treatment with or without hematopoietic stem cell transplantation (HSCT) consolidation.  AML patients with the FLT3 mutation tend to have a poorer prognosis than those whose cancers are FLT3 negative.

“Daiichi Sankyo is the ideal organization to take quizartinib to the next stage of development, and ultimately, to achieve our goal of making it available as quickly as possible to help as many AML patients as possible,” said Michael A. Martino, President and CEO, Ambit Biosciences.  “This attractive offer to shareholders, is a testament to the hard work and dedication of the Ambit team to our mission of developing innovative therapies for areas of high unmet medical need.”

“The acquisition of Ambit Biosciences further builds our presence in oncology to ensure we are delivering on our goal of providing world-class, innovative pharmaceuticals in core areas of unmet medical need,” said Daiichi Sankyo Co., Ltd. President and CEO, Joji Nakayama. “Long-term success in oncology depends upon three pillars:  fostering development of our in-house molecules, exploring mutually beneficial partnerships and executing strategic purchases, such as Ambit Biosciences, which follows our acquisitions of U3 Pharma and Plexxikon.”

“Quizartinib will fit seamlessly into our already robust oncology pipeline focused on targeted therapies with the potential for personalizing the treatment of cancer,” said Mahmoud Ghazzi, MD, PhD, Global Head of Development for Daiichi Sankyo.  “With the acquisition of Ambit Biosciences, Daiichi Sankyo gains additional opportunities to develop promising treatments for cancer, including the global rights to quizartinib, currently being studied in patients with refractory AML, a very serious condition for which no new therapies have been approved for more than 30 years.”

Ambit Biosciences board of directors has unanimously approved the acquisition.

Closing of the tender offer and merger is subject to certain conditions, including the tender of more than 50 percent of all shares of Ambit Biosciences.  Completion of the transaction is also subject to clearance under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act and customary closing conditions.  The acquisition is expected to conclude promptly after receipt of HSR clearance and the close of the tender period.

Centerview Partners acted as lead financial advisor to Ambit Biosciences.  Leerink Partners LLC also acted as financial advisor to Ambit Biosciences. Cooley LLP acted as legal advisor to Ambit Biosciences.   Simpson Thacher & Bartlett LLP acted as legal advisor to Daiichi Sankyo.

About Daiichi Sankyo
Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical products to address the diversified, unmet medical needs of patients in both mature and emerging markets. While maintaining its portfolio of marketed pharmaceuticals for hypertension, dyslipidemia and bacterial infections used by patients around the world, the Group has also launched treatments for thrombotic disorders and is building new product franchises.  Furthermore, Daiichi Sankyo research and development is focused on bringing forth novel therapies in oncology and cardiovascular-metabolic diseases, including biologics.  The Daiichi Sankyo Group has created a “Hybrid Business Model,” to respond to market and customer diversity and optimize growth opportunities across the value chain. For more information, please visit: www.daiichisankyo.com.

The Daiichi Sankyo oncology portfolio continues to grow and currently includes both small molecules and monoclonal antibodies with novel targets in both solid and hematologic cancers.

About Ambit Biosciences
Ambit is a biopharmaceutical company focused on the discovery, development and commercialization of drugs to treat unmet medical needs in oncology, autoimmune and inflammatory diseases by inhibiting kinases that are important drivers for those diseases. Ambit’s lead drug candidate, quizartinib (AC220), is a once-daily, orally-administered potent and selective, inhibitor of FMS-like tyrosine kinase-3 (FLT3) and is currently in a registrational phase 3 clinical trial, referred to as QUANTUM-R, in patients with relapsed/refractory FLT3-ITD positive, acute myeloid leukemia (AML). Quizartinib is also being studied in newly diagnosed patients in combination with chemotherapy as well as maintenance following a hematopoietic stem cell transplantation (HSCT). In addition to quizartinib, Ambit’s clinical pipeline includes AC410, an oral JAK2 inhibitor, and CEP-32496, a BRAF inhibitor licensed to Teva Pharmaceutical Industries Ltd. Ambit’s preclinical portfolio includes a proprietary CSF1R inhibitor program.

About AML

AML is the most common type of acute leukemia in adults and is projected to account for approximately 36 percent of all new leukemia cases in 2014. AML results in uncontrolled growth and accumulation of malignant white blood cells which fail to function normally and interfere with the production of normal blood cells.

According to the American Cancer Society, approximately 18,860 patients will be newly diagnosed with AML in 2014 in the United States and approximately 10,460 are expected to die of the disease in 2014. AML is generally a disease of older people and the median age of a patient at initial diagnosis is 66 years. The five-year survival rate for all AML patients, irrespective of age and FLT3-ITD status, is 23 percent.

The standard of care for AML has not changed appreciably for decades. Treatment decisions for AML are typically based on the patient’s age (60 years of age being generally referred to as “elderly” and used as a treatment indicator), overall health, cytogenetics and molecular abnormalities such as FLT3-ITD status. These factors determine the aggressiveness of the treatment approach given the high toxicity associated with currently approved treatment options for AML. Importantly, the National Comprehensive Cancer Network recommends participation in clinical trials as a treatment option for all AML patients.

The goal of treatment in AML is to reduce the blasts in the bone marrow to below 5 percent and return the blood cell counts to normal levels. A bone marrow transplant is generally recognized as the only curative treatment option. Typically, patients who are able to achieve a reduction in bone marrow blasts below 5% are more suitable candidates for transplant and have an improved projected outcome.

Important Additional Information
This press release is for informational purposes only and is not an offer to buy or the solicitation of an offer to sell any shares of Ambit Biosciences common stock. The tender offer described herein has not yet been commenced. On the commencement date of the tender offer, an offer to purchase, a letter of transmittal and related documents will be filed with the Securities and Exchange Commission (SEC). The solicitation of offers to buy shares of Ambit Biosciences common stock will only be made pursuant to the offer to purchase, the letter of transmittal and related documents. Investors and Ambit Biosciences securityholders are strongly advised to read both the tender offer statement and the solicitation/recommendation statement that will be filed by Ambit Biosciences regarding the tender offer when they become available as they will contain important information. Investors and securityholders may obtain free copies of these statements (when available) and other documents filed with respect to the tender offer at the SEC’s website at www.sec.gov. In addition, copies of the tender offer statement and related materials (when available) may be obtained for free by directing such requests to the information agent for the tender offer or by directing such requests to the Daiichi Sankyo Group investor relations at the e-mail address below. The solicitation/recommendation statement and related documents (when available) may be obtained by directing such requests to Ambit Biosciences investor relations at the phone number or e-mail address below.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements. Any statements contained herein which do not describe historical facts, including but not limited to, statements regarding: the proposed transaction between Daiichi Sankyo and Ambit Biosciences; the expected timetable for completing the transaction; strategic and other potential benefits of the transaction; Ambit Biosciences’ product candidates, including regarding the therapeutic and commercial potential of quizartinib; and any other statements about  Daiichi Sankyo or Ambit Biosciences managements’ future expectations, beliefs, goals, plans, or prospects, are forward-looking statements which involve risks and uncertainties that could cause actual results to differ materially from those discussed in such forward-looking statements. Such risks and uncertainties include: the possibility that certain closing conditions to the transaction will not be satisfied; that required regulatory approvals for the transaction may not be obtained in a timely manner, if at all; the ability to timely consummate the transaction and possibility that the transaction will not be completed; the ability of Daiichi Sankyo to successfully integrate Ambit Biosciences operations and employees; the anticipated benefits of the transaction may not be realized; risks related to drug development and commercialization; and those additional factors discussed in Ambit Biosciences’ most recent Quarterly and Annual Reports on Forms 10-Q and 10-K filed with the Securities and Exchange Commission. Daiichi Sankyo and Ambit Biosciences caution investors not to place considerable reliance on the forward-looking statements contained in this press release. These forward-looking statements speak only as of the date of this document, and Daiichi Sankyo and Ambit Biosciences undertake no obligation to update or revise any of these statements.

Contacts:
Daiichi Sankyo
Tokyo Media and Investor Relations:
Yasuki Minobe
Daiichi Sankyo Co., Ltd.
minobe.yasuki.eg@daiichisankyo.co.jp
+81-3-6225-1126

US Media Relations:
Kimberly Wix (US)
Daiichi Sankyo, Inc.
kwix@dsi.com
+973 944 2338

Ambit Biosciences
Marcy Graham
Executive Director, Investor Relations & Corporate Communications
Ambit Biosciences Corporation
mgraham@ambitbio.com
858-334-2125

Monday, September 29th, 2014 Uncategorized Comments Off on (AMBI) Daiichi Sankyo to Acquire Ambit Biosciences

(VAPOD) Announces Engagement of QualityStocks Investor Relations Services

SCOTTSDALE, AZ–(Sep 29, 2014) – Vaporin, Inc. (OTCQB: VAPOD) today announces that it has agreed with QualityStocks to be featured in The Small Cap QualityStocks Daily Newsletter, QualityStocks Daily Blogs and Message Boards. QualityStocks, based in Scottsdale, Arizona, is a free service that collates data from hundreds of Small-Cap online Investment Newsletters into one Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their investor communication efforts.

You can SIGN UP NOW http://Signup.QualityStocks.net

Vaporin distributes and markets vaporizers, e-liquids and e-hookah products, operating a growth strategy that includes convenience store sales and online retail continuity programs as well as brick and mortar retail stores. The company’s flagship vapor technology provides the look, feel and taste of traditional cigarettes without any tar, tobacco, smoke and odor, offering a higher quality experience with a more satisfying hit compared to e-cigarettes. Vaporizers also offer the ability to mix and match flavors, and can be used to consume cannabis in oil, wax and dry herb form.

Responding to rapid increases in the popularity and demand for vapor technology, Vaporin is expanding its Vape Store retail locations via acquisition and new store openings. Part of this growth strategy also includes ramping up brand and product visibility.

“Our multi-pronged revenue model is a perfect fit for the explosive growth of the vapor market. As we utilize this strategy to increase company and shareholder value, we’re also meeting incredible consumer demand. The supporting step for this plan is to relay our progress to the investment community while pushing brand awareness to an unprecedented level through our partnership with the QualityStocks team,” stated Vaporin Chief Executive Officer Scott Frohman.

QualityStocks will utilize its vast network of marketing tools to assist Vaporin with its shareholder communication and brand/product awareness strategies. This campaign includes Vaporin’s placement in the QualityStocks Newsletter, Video, Blog and more.

“Vaporin is in a unique and aggressive position to capture more than its fair share of the growing the vapor market,” stated QualityStocks Managing Director Michael McCarthy. “We’re excited to partner the company’s innovative management team to help Vaporin realize and exceed its market potential. We look forward to helping the company power through the market with strong visibility, communication and transparency.”

About Vaporin, Inc. (VAPOD)

Vaporin is a distributor and marketer of vaporizers and e-liquids products. The Company focuses on a multi-pronged revenue model comprised of convenience store sales, online retail continuity programs and the acquisition and opening of brick and mortar retail stores. Vaporin’s innovative technology offers the look, feel and taste of traditional cigarettes without any tar, tobacco, smoke and odor. As an alternative to traditional cigarettes, Vaporin is offered in a variety of disposable and rechargeable starter kits and flavors. The unique Vaping Pens product line and Made-In-USA E-Liquid is what makes Vaporin one of the emerging brands in the market. Vaporin is not just an alternative to traditional smoking, but a lifestyle.

For more information on Vaporin, Inc., visit: http://VAPOD.QualityStocks.net

About QualityStocks

Small Cap Stock Newsletter QualityStocks is a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters into one free Daily Newsletter Report. QualityStocks also utilizes social media and networking to maintain constant communication with its rapidly growing audience. To date, QualityStocks has more than one million users following various social networking accounts.

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

The QualityStocks Blog keeps investors up to date on everything related to the Small-Cap and Micro-Cap markets. Alternative fuels and power sources, entertainment media, telecommunications, delivery services, healthcare, and retail are all covered on a regular basis. By visiting our blog, investors also discover emerging companies that they otherwise would not have heard about. To date, more than 20,000 articles have been published via the QualityStocks Blog.

The message board here at QualityStocks is one of the most highly regulated, no-nonsense forums online today; an uncommon haven of highly relevant, SPAM-free investor interaction. Unlike the majority of boards currently in operation, you won’t find pumping, bashing, advertising, or malicious posting of any kind here. The QualityStocks Message Boards has over 34,000 registered users.

With all of the stock picks and recommendations available today in the investment world, selecting and deciding on the right stocks can be tedious and time consuming. At QualityStocks, we collate hundreds of investment newsletters into The ONE and ONLY “The QualityStocks Daily,” featuring a summary format in which you can view the latest stock picks EVERYDAY.

You can SIGN UP NOW http://Signup.QualityStocks.net

Forward-Looking Statements:

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company’s SEC filings. These risks and uncertainties could cause the company’s actual results to differ materially from those indicated in the forward-looking statements.

Contact:

QualityStocks
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336
editor@QualityStocks.net

Monday, September 29th, 2014 Uncategorized Comments Off on (VAPOD) Announces Engagement of QualityStocks Investor Relations Services

(CNET) Participated in 2014 Sina Supporting Wings Corporate Marketing Summit

BEIJING, Sept. 25, 2014  — ChinaNet Online Holdings, Inc. (Nasdaq:CNET) (“ChinaNet” or the “Company”), a leading B2B (business to business) Internet technology company providing online-to-offline (O2O) sales channel expansion services for small and medium-sized enterprises (SMEs) and entrepreneurial management and networking services for entrepreneurs in the People’s Republic of China, announced today that ChinaNet participated in 2014 Sina Supporting Wings Corporate Marketing Summit by Sina with growing perspectives on new digital advertising and marketing product. Nearly a thousand advertisers from the apparel, tourism and education sectors, as well as others, participated in the event.

Supporting Wings is a marketing tool designed to get company information in front of Sina users, accurately delivering messaging based on user attributes and social relationships within the target population. Supporting Wings complements ChinaNet Online offerings with a focus on providing precision marketing tools to customers. The Supporting Wings solution is individually tailored to each user, and will help companies increase awareness and address the typical issues that arise in marketing. Supporting Wings will also offer consulting services and professional training to clients.

The tool integrates data from Sina, China’s mainstream media portal, and other popular shopping platforms such as Taobao and T-Mall, making it possible to track all related internet behavior and customer interests and precisely target customers with products that interest them. As a result, advertising will be more effective, leading to more clicks and ultimately more purchases.

ChinaNet COO George Chu said, “It is an honor to participate in this event to further communicate with the industry and explore the working relationship between Sina and other participants. Supporting Wings is definitely a cutting edge marketing tool and, combined with ChinaNet’s Micro-Sell 360, can increase the volume and depth of sales leads provided to businesses both small to large. Internet marketing is becoming more and more complicated, and a high volume of information is transmitted and exchanged. Significant technology and analysis is necessary to generate actionable sales information that will cost-effectively boost sales. The future promises to be even more exciting for internet and mobile digital marketing as we are getting more and more direct and personalized. I believe ChinaNet’s growth will explode when smart phone usage peaks over the next two years in China with the big data we have accumulated in years of operation. Having an additional stream of growing revenues from B2C sales leads should create a new era for the company, while we further perfect the depth and quality of B2B sales leads.”

About ChinaNet Online Holdings, Inc.

The Company, a parent company of ChinaNet Online Media Group Ltd., incorporated in the BVI (“ChinaNet”), is a leading digital B2B (business to business) Internet technology company focusing on providing online to offline (O2O) sales channel expansion service for small and medium-sized enterprises (SMEs) and entrepreneurial management and networking service for entrepreneurs in China. The Company, through certain contractual arrangements with operating companies in the PRC, provides Internet advertising and other services for Chinese SMEs via its portal websites, 28.com, Liansuo.com and Chuangye.com, TV commercials and program production via China-Net TV, and in-house LCD advertising on banking kiosks targeting Chinese banking patrons. Website: http://www.chinanet-online.com.

Safe Harbor

This release contains certain “forward-looking statements” relating to the business of ChinaNet Online Holdings, Inc., which can be identified by the use of forward-looking terminology such as “believes,” “expects,” “anticipates,” “estimates” or similar expressions. Such forward-looking statements involve known and unknown risks and uncertainties, including business uncertainties relating to government regulation of our industry, market demand, reliance on key personnel, future capital requirements, competition in general and other factors that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Certain of these risks and uncertainties are or will be described in greater detail in our filings with the Securities and Exchange Commission. These forward-looking statements are based on ChinaNet’s current expectations and beliefs concerning future developments and their potential effects on the Company. There can be no assurance that future developments affecting ChinaNet will be those anticipated by ChinaNet. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond the control of the Company) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by such forward-looking statements. ChinaNet undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

CONTACT: MZ North America
         Ted Haberfield, President
         Direct: +1-760-755-2716
         Email: thaberfield@mzgroup.us
         Web: www.mzgroup.us
Thursday, September 25th, 2014 Uncategorized Comments Off on (CNET) Participated in 2014 Sina Supporting Wings Corporate Marketing Summit

(AFYG) Announces Update Regarding its Regulatory Filing Status

MAPLE GROVE, MN, United States, via ETELIGIS INC., 09/25/2014 – – Affinity Gold Corp., (OTC Pink: AFYG) (PINKSHEETS:AFYG) (Affinity or the Company), is extremely pleased to announce an update regarding the Companys progress towards becoming compliant with its regulatory obligations with the U.S. Securities and Exchange Commission (the SEC).

On Monday, September 22nd, 2014, Affinity filed an amended Form 8-K filing with the SEC which is an amendment to the Companys Form 8-K originally filed May 13th, 2009 and subsequently amended August 21, 2009 and September 2, 2009 in order to file unaudited US GAAP financial statements of AMR Project Peru S.A.C. (AMR) covering periods prior to the Companys merger on August 14, 2009 along with pro forma financial statements with will account for the transaction as a merger of entities under common control.

This first amended Form 8-K filing marks another significant accomplishment for the Company as it establishes the baseline for all subsequent filings going forward. Furthermore, this filing demonstrates the Company has been able to work through all its challenges including receiving confirmation and direction from the SEC for how the Company can best proceed in accomplishing its goal of becoming compliant with its regulatory obligations, stated President & CEO, Mr. Corey J. Sandberg.

Next, management will focus on its comprehensive Form 10-K filing which will include audited financial statements for the nine-month transition period in 2009, associated with the Companys change in fiscal year-end to December 31st, along with each subsequent fiscal year through December 31, 2013. In addition, the comprehensive Form 10-K filing will contain all information that would have been otherwise required for these periods, including quarterly and year-to-date interim financial statements for each period within those fiscal years, a comprehensive business discussion and MD&A pertaining to all periods. All annual and interim financial statements covered within the comprehensive Form 10-K filing will be presented on a comparative basis.

This recent accomplishment now allows Affinity to resume execution against our overall strategy to grow the company which is dependent on being fully compliant with its regulatory obligations providing shareholders financial transparency of the Company. Upon completion of filing our comprehensive Form 10-K and interim quarterly periods for 2014, the Company intends to then apply to regain its OTCQB status, stated President & CEO, Mr. Corey J. Sandberg.

About Affinity Gold Corp.:

Affinity Gold Corp. is a mineral exploration and development company engaged in the acquisition and development of near-term precious mineral production properties within Peru. Affinity Gold Corp.s primary focus is on developing assets that have demonstrated historical production, contain documented and reliable data and can reasonably begin producing within 12-18 months at a cost of less than $900 per gold equivalent ounce.

www.affinitygold.com

For further information please refer to the Companys filings with the SEC on EDGAR available at www.sec.gov

FORWARD-LOOKING STATEMENTS

This news release may include “forward-looking statements” regarding Affinity Gold Corp., and its subsidiaries, business and project plans. Such forward-looking statements are within the meaning of Section 27A of the Securities Act of 1933, as amended, and section 21E of the United States Securities and Exchange Act of 1934, as amended, and are intended to be covered by the safe harbor created by such sections. Where Affinity Gold Corp. expresses or implies an expectation or belief as to future events or results, such expectation or belief is believed to have a reasonable basis. However, forward-looking statements are subject to risks, uncertainties and other factors, which could cause actual results to differ materially from future results expressed, projected or implied by such forward-looking statements. Affinity Gold Corp. does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

CONTACT:

AFFINITY GOLD CORP.

Corey J. Sandberg

763-424-4754

csandberg@affinitygold.com

Thursday, September 25th, 2014 Uncategorized Comments Off on (AFYG) Announces Update Regarding its Regulatory Filing Status

(FBEC) Issues Company Update

HENDERSON, NV, United States, via ETELIGIS INC., 09/25/2014 – – Frontier Beverage Company Inc., (OTC Pink: FBEC) (PINKSHEETS: FBEC), issues company update.

From Frontier Beverage Company President, William Coogan, Over the past weeks I have received inquiries for a company update, future plans etc. and do apologize if I wasnt able to get back with everyone and also would like to thank everyone for their patience. As I have executing on the company business plan which again calls for the reduction of debt, additional acquisitions and/or partnership relationships for the increase of revenues and to produce profits and as I have promised transparency the following is the most current information with regard to the company operations:

– In continued cost cutting moves all consulting and independent contractor contracts (Including Mr. Leiewands) have been terminated and all payments were paid and/or satisfied in the last quarter or within the 3A10 fling dated June 6, 2014. No further fees are owed to consultants and no shares were issued in this quarter to consultants or independent contractors.

– The company has entered into two new debt reduction contracts, a new 3A10 dated and filed September 11, 2014 for the amount of $56,749.25 as well as a separate conversion note for the amount of $30,000 (8k to follow). These debts have been on the books for many years. Additionally our $50,000 Convertible Debenture has matured and conversions have begun on that note as well.

– I have no plans for any stock split whatsoever, but due the recent contractual obligations we found it necessary to increase the authorized to satisfy our obligations.

– The company has been interviewing new candidates for management and I will be making an announcement in coming days as to the hiring of our new President. Our search curriculum included Energy experience as well as a strong business Background.

– With regard to our recent signing of the Oil Patch Marketing contract, I will hold off those discussions until our new President is in place.

– With regard to share issuance, the only shares issued this quarter were from debt note conversions

– I will request that new management be more forthcoming with updates via Press Releases, Twitter or via Blog posting.

I understand shareholder frustration with regard to the company slumping stock price, but as I inherited the aged debt and I have found that debt reduction a necessary part of the future growth of the company. And as former management ignored the problem, I took it head on and as it is a short term inconvenience, it will only help for our long term growth. Please keep in mind this is Marathon not a Sprint. As there have been discussions for new business opportunities it seems the debt is the main focus of the conversion. So with that in mind and with the assistance of the Private Equity and Hedge Fund community, I thought it best we deal with it and eliminate it!

Safe Harbor:

This press release contains forward-looking statements. Such forward-looking statements are subject to a number of risks, assumptions and uncertainties that could cause the Company’s actual results to differ materially from those projected in such statements. Forward-looking statements speak only as of the date made and are not guarantees of future performance. We undertake no obligation to publicly revise any forward-looking statements.

Contact:

William Coogan, President

Info@FrontierBeverageco.com

#FRONTIERBEVERAGE – TWIITTER

(307) 222-6000

Thursday, September 25th, 2014 Uncategorized Comments Off on (FBEC) Issues Company Update

(AXST) Acquires Flexcomm Limited

Axesstel (OTCQB: AXST) announced today that is has acquired Flexcomm Limited of Hong Kong in a stock for stock acquisition. Flexcomm Limited’s operating subsidiaries include Flexcomm Technology (Shenzhen) Ltd., a designer and manufacturer of network security devices based in Shenzhen, China, and PT Scan Nusantara, a provider of network security services based in Jakarta, Indonesia.

“The Flexcomm acquisition accomplishes several of our immediate strategic objectives,” said Pat Gray, chief executive officer of Axesstel. “Flexcomm extends our product offerings into additional network communication and security devices. The PT Scan business takes us into network security management on a recurring revenue business model. Finally, the combination provides a platform to take our Home Alert products into Asia, and to access new business opportunities in the rapidly developing Southeast Asia region.”

Flexcomm Limited, founded in 2004, is a provider of wired and wireless routers, modems and other devices for Network Communication, Network Multimedia and Consumer Multimedia products and solutions. Flexcomm Limited, together with Flexcomm Shenzhen, employs a team of mechanical, hardware and software engineers in Shenzhen, China. For the past two years, Flexcomm Limited’s largest selling product has been a network security appliance that has been sold to distributors and value added resellers in Europe and Asia.

Flexcomm Limited owns 85% of PT Scan Nusantara, also founded in 2004, which is engaged in the business of providing network security services, primarily to commercial banks and government agencies in Indonesia. PT Scan operates a network security center which monitors network activity for its customers 24 hours a day, seven days a week. The security monitoring business is based on long term contracts which typically provide for multi-year terms with quarterly payments made in advance. PT Scan is also branching into offering systems integration and managed services for telecommunications providers for the rapidly growing telecommunications market in Indonesia and other Southeast Asian countries.

Flexcomm Limited was founded by Dato’ Michael Loh Soon Gnee. Dato’ Loh has had a distinguished career in the semiconductor industry with more than 34 years of experience in wafer fabrication, research and development and assembly, testing and distribution of semiconductor products. Dato’ Loh is currently the Executive Chairman and Chief Executive Officer of: ASTI Holdings Limited (SGX:AITH.SI), a publicly-traded company engaged in the business of researching, designing, developing and manufacturing semiconductor equipment; Advanced Systems Automation Limited (SGX:ASDA.SI), a publicly-traded provider of automated semiconductor backend process equipment and precision engineering manufacturing services; Dragon Group International (SGX:DRGN.SI), a publicly-traded investment holding company; Chief Executive Officer of Eoplex, Inc., a Silicon Valley HVPF™ Print-Forming process technology company; and Dragon Technology Distribution Pte. Ltd., a pan-Asia company with operating subsidiaries engaged in the electronic components distribution business. In connection with this transaction, Dato’ Loh has become Axesstel’s largest stockholder and was appointed to Axesstel’s Board of Directors.

“This transaction is a good match for both companies,” said Dato’ Michael Loh. “The combined company has core competencies in key product and service areas for network communications and security. With operating bases in the United States, China and Indonesia, we have access to key markets for talent, financial resources, manufacturing and service. We believe that we are particularly well positioned to access the markets in the Southeast Asia region, where we expect to see strong demand for computing and communications for several years.”

Concurrently with the Flexcomm Limited acquisition, Axesstel secured an additional $1.2 million equity financing with Dato’ Loh. Pursuant to the terms of a Subscription Agreement, Axesstel sold 6.0 million shares of its common stock to Dato’ Loh for an aggregate purchase price of $1.2 million, or $0.20 per share. Axesstel has agreed to use a portion of the proceeds from the financing to provide working capital to PT Scan Nusantara to support the development of its business.

In connection with the acquisition, Axesstel issued an aggregate of 25.0 million shares of its common stock to the former Flexcomm Limited stockholders. Axesstel has filed a current report on Form 8-K with respect to the Stock Purchase Agreement and the Subscription Agreement. Additional information about the terms of the acquisition, including details of a potential earn out payment and additional agreements between the parties can be found in that report on the SEC’s website at www.sec.gov.

About Axesstel, Inc.

Axesstel (OTCQB: AXST) is a provider of wireless voice, broadband access and connected home solutions for the worldwide telecommunications market. Axesstel’s best in class product portfolio includes phones, wireline replacement terminals, security alert systems, and 3G and 4G broadband gateway devices. These products are used for voice calling, high-speed data access, and connected home management services. The company has supplied millions of devices to leading telecommunications operators and distributors in over 50 countries worldwide. Axesstel is headquartered in San Diego, California. For more information on Axesstel, visit www.axesstel.com.

About Flexcomm Limited.

Flexcomm Limited was founded in 2004 and is a world leading provider of Network Communication, Network Multimedia and Consumer Multimedia products and solutions which are based on Intel® network processors, Intel® XScale® technology, Marvell® PXA and Armada processor, Atheros, Broadcom, MTK, and Sigma Designs technology. Flexcomm Limited strives to develop best in class products and solutions to meet the global market’s growing demands for faster, more compatible and easy-to-use solutions. Flexcomm Limited’s passion and understanding of network and embedded technology and its customers’ requirements enable it to help its customers go to market more quickly with lower risk. Flexcomm Limited is headquartered in Hong Kong, with offices in Shenzhen, China. and Penang, Malaysia.

About PT Scan Nusantara.

PT Scan Nusantara was founded in 2004 and is a leading provider of network security solutions and services. PT Scan Nusantara operates a network security center that monitors network activity for its customers 24 hours a day, seven days a week. The company is a trusted provider of security solutions and services to some of the largest financial and commercial institutions in Indonesia.

“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: With the exception of historical information, the statements set forth above include forward-looking statements relating to the anticipated benefits to be received from the Flexcomm Limited acquisition, the timing and success of product launches, the ability to expand Axesstel’s business and penetrate new markets, the availability of new business opportunities and Axesstel’s ability to execute on those opportunities. Axesstel wishes to caution readers that actual results could differ materially from those suggested by the forward-looking statements due to risks and uncertainties and a number of important risk factors. Those factors include but are not limited to the risk factors noted in Axesstel’s filings with the Securities and Exchange Commission, including the need for additional working capital; economic and political instability in developing markets served by Axesstel; unforeseen manufacturing difficulties, unanticipated component shortages, competitive pricing pressures and the rapidly changing nature of technology and frequent introductions of new products and enhancements by competitors; the competitive nature of the markets for Axesstel’s products; product and customer mix; Axesstel’s need to gain market acceptance for its products; dependence on a limited number of large customers; potential intellectual property-related litigation; Axesstel’s need to attract and retain skilled personnel; and Axesstel’s reliance on its contract manufacturers. All forward-looking statements are qualified in their entirety by this cautionary statement, and Axesstel undertakes no obligation to revise or update this press release to reflect events or circumstances occurring after this press release.

Thursday, September 25th, 2014 Uncategorized Comments Off on (AXST) Acquires Flexcomm Limited

(APPZ) Adding 10,000 Top Travel Businesses to Popular Website and App

Orange County, CA / September 25, 2014 / Travel America Visitor Guide (TAVG), a division of Monster Arts, Inc. (OTCQB: APPZ), today announces the next step in building out the fast growing group of travel destination related businesses, recreation, and amusement destinations in their popular travel destination website and directory.

While TAVG continues to add annual recurring paying members at a record rate, TAVG is now in the process of qualifying top travel destination businesses and recreation locations and adding them to the directory website and corresponding Smartphone apps.

“These new qualified business, recreation, and quick-stop destinations now being added will poise the TAVG website and apps to take the promotional offerings to member businesses to the next level, while adding a much more rewarding experience for the service users.” commented Wayne Irving CEO, Monster Arts.

A special group of TAVG employees and consultants have been assembled to investigate, and quality control information and offerings about the highest ranked local businesses in cities where TAVG has featured paying clients and members. Currently, the group is adding up to 200 qualified associate members to the companies searched database per day, with a goal of 10,000 qualified associate and or recurring featured members by year end.

About Travel America Visitor Guide (TAVG):

Originally a group of more than 400 websites and Smartphone apps, and now combined into one comprehensive, convenient and highly accessible online directory, Travel America Visitor Guide is a concept that takes advantage of the ever-burgeoning travel industry by providing an exclusive directory of investigated, reviewed or otherwise credentialed places to stay, places to eat, places to shop and other things to do for the consumer and business traveler. TAVG is a wholly owned division of Monster Arts, Inc. (OTCQB:APPZ) and is committed to providing its membership with the ability to develop and maintain an intimate connection between their businesses and potential consumers or customers who look to have the best experiences while traveling.

Monster Arts Contact:
(877) 733-6133
info@monsterarts.net

Safe Harbor Statement:

Any statements contained in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including, but not limited to, the risks associated with the management appointment described in this press release, and other risks identified in the filings by Monster Arts, Inc. (APPZ), with the U. S. Securities and Exchange Commission. Further information on risks faced by APPZ are detailed in the Form 10-K for the year ended December 31, 2013, and in its subsequent Quarterly Reports on Form 10-Q. These filings are or will become available on a website maintained by the U. S. Securities and Exchange Commission at http://www.sec.gov. The information contained in this press release is accurate as of the date indicated. Actual results, events or performance may differ materially. Monster Arts does not undertake any obligation to publicly release the any revision to these forward-looking statements that may be made to reflect events or circumstances occurring after the date hereof or to reflect the occurrence of unanticipated events. Included in this release are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Although the company believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations reflected in such forward-looking statements will prove to have been correct. The company’s actual results could differ materially from those anticipated in the forward-looking statements

Thursday, September 25th, 2014 Uncategorized Comments Off on (APPZ) Adding 10,000 Top Travel Businesses to Popular Website and App

(VAPOD) Continues Expansion of The Vape Store Retail Locations

MIAMI, FL–(Sep 23, 2014) – Vaporin, Inc. (OTCQB: VAPOD), a distributor and marketer of vaporizers and e-liquids products, today announced they have signed a lease for the opening of another Vape Store. Located in North Fort Myers, Florida, the new store is positioned in a highly visible and heavily trafficked area. The Company is using cash flow from existing Vape Store locations to fund the development of the new store; no additional investment is needed.

Retail store sales continue to be one of the fastest growing segments of the vapor market. In fact, the number of vape stores have tripled over the last year. According to a recent report issued by Wells Fargo, the e-cigarette market has decreased $400 million from $1.4 billion to $1 billion while vaporizers, tanks, and mods have increased $400 million from $1.1 billion to $1.5 billion. The retail vape store segment alone has also grown to be a $1 billion market.

The Company recognizes this trend and is focused on the expansion of The Vape Store retail locations. Vaporin, Inc. has plans to aggressively accelerate the growth of their retail store model with continued acquisitions of existing stores as well as opening new store locations. Currently, the Company forecasts approximately $650,000 in annual revenue per vape store.

CEO Scott Frohman said, “The opening of another Vape Store is part of our strategy to continuously build out our multi-pronged revenue model. We are very pleased with the production from our current Vape Stores as the cash flow generated has enabled us to build out this new location without taking on any additional investment. This allows us to increase shareholder equity as we continue to execute on our business plan. We are very confident in our ability to quickly turn retail stores cash flow positive and will continue to move aggressively towards expanding our retail store, online sales and distribution market shares.”

About Vaporin, Inc.
Vaporin is a distributor and marketer of vaporizers and e-liquids products. The Company focuses on a multi-pronged revenue model comprised of convenience store sales, online retail continuity programs, vending machines, and the acquisition and opening of brick and mortar retail stores. Vaporin’s innovative technology offers the look, feel and taste of traditional cigarettes without any tar, tobacco, smoke and odor. As an alternative to traditional cigarettes, Vaporin is offered in a variety of disposable and rechargeable starter kits and flavors. The unique Vaping Pens product line and Made-In-USA E-Liquid is what makes Vaporin one of the emerging brands in the market. Vaporin is not just an alternative to traditional smoking, but a lifestyle. For more information please visit, www.vaporin.com.

Cautionary Note Regarding Forward Looking Statements
This press release contains forward-looking statements including statements regarding future Vape Store acquisitions and opening new Vape Stores. The words “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “will,” “expect” and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Important factors that could cause actual results to differ from those in the forward-looking statements include the results of our marketing efforts including our online initiative, competition from other e-cig. companies and the major tobacco companies, our ability to efficiently and productively integrate our recent acquisition, our future stock price and cash resources, and new regulations which affect the distribution of these products. Further information on our risk factors is contained in our filings with the SEC, including the Form 10-K filed on March 27, 2014. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.

All of the securities were issued and sold in reliance upon the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933 (the “Act”) and Rule 506 promulgated thereunder. These securities may not be offered or sold in the United States in the absence of an effective registration statement or exemption from the registration requirements under the Act. The investors are accredited investors and there was no general solicitation.

Contact:

Company
Vaporin, Inc.
Scott Frohman
Chief Executive Officer
305.842.2813
Email Contact

Investor Relations
Capital Markets Group, LLC
Valter Pinto
PH: (914) 669-0222 x201
or
(212) 398-3486
Email Contact

Thursday, September 25th, 2014 Uncategorized Comments Off on (VAPOD) Continues Expansion of The Vape Store Retail Locations

(OWOO) One World Doll Project Financing Relationship w/ NY Hedge Fund, Blackbridge

HOUSTON, TX–(Sep 24, 2014) – The One World Doll Project, a subsidiary of One World Holdings, Inc. (OTCQB: OWOO), announced today that it has recently entered into an $800,000 private equity partnership with Blackbridge Capital, a New York hedge fund, and a group of private equity investors that will focus on debt reduction and balance sheet enhancement.

“Over the past 18 months, the company has taken on several large convertible notes that have had the unfortunate effect of creating derivative liabilities on our balance sheet and downward pressure on our stock price as a result of simultaneous conversions of those notes into stock at a substantial discount to market,” stated Joanne Melton, CEO of One World Holdings. “By the end of the 3rd quarter we will have consolidated and eliminated several of our most expensive institutional and private convertible notes totaling over $415,000. The purpose of this initiative is to phase out at least 50% of the total company debt by the end of 2014,” she added.

“We are thrilled to partner with One World Holdings while enhancing their balance sheet, increasing shareholder value, and providing advice on business plan execution,” said Alexander Dillon, Co-Founder and Chief Investment Officer of Blackbridge Capital. “We are also extremely proud of the diligent efforts of the One World management team as we work together to eliminate derivative liabilities and secure key business development milestones, including the most recent achievement of locking up a premier spot at Toy Fair 2015 where the company will unveil its new line of Prettie Girls! dolls created in partnership with Robert Tonner and The Tonner Doll Company.”

About The One World Doll Project

Established in 2010 by Trent T. Daniel and Stacey McBride-Irby, The One World Doll Project endeavors to make a significant positive cultural impact through the doll category. The company’s beautiful dolls are unique works of art, created for a growing market yearning for something unique to experience — a doll that both embraces contemporary girls of many races and symbolizes the women they can become. The One World Doll Project has created The Prettie Girls!™ dolls, an exciting line of multi-cultural fashion dolls, years in development, recently launched in the marketplace. The Prettie Girls!™ are unique in their look, their backgrounds and their stories, capturing the essence of values and positive attributes that every little girl can embrace. Styled for play, yet filled with soul, The Prettie Girls!™ set new, higher, values-based standards for “pretty” — positive goals that reach across the globe and up for the stars!

For young girls, The One World Doll Project creates a doll that is a friend, a partner in play, and a glimpse of their biggest, brightest dreams. For young women, it is a symbol of who they are, how much they can achieve, and a keepsake of the best times of their lives. For connoisseurs, The One World Doll Project promises stylish works of art that will become a vital part of a valuable growing collectors’ market. More information about One World Holdings, Inc., Stacey McBride-Irby, Trent T. Daniel and The One World Doll Project can be found at www.oneworlddolls.com.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above; and the Company expressly disclaims responsibility to update the information included herein for events occurring after the date hereof.

Investor Relations Contact:

One World Holdings, Inc.
ir@oneworlddolls.com
(281) 497-1311

Wednesday, September 24th, 2014 Uncategorized Comments Off on (OWOO) One World Doll Project Financing Relationship w/ NY Hedge Fund, Blackbridge

(LPCN) Positive Top-Line Results Phase 3 LPCN 1021 Oral Testosterone Replacement

  • Met primary efficacy endpoint by successfully restoring testosterone levels to the normal range in 88% of the subjects
  • Lower limit of the 95% confidence interval was 82%
  • 85% of the subjects reached final dose with no more than one dose titration
  • Majority of subjects ended on 225 mg BID
  • Proportion of subjects with maximum serum concentrations generally met FDA pre-specified targets
  • LPCN 1021 treatment was well tolerated with no drug related serious adverse events

SALT LAKE CITY, Sept. 24, 2014  — Lipocine Inc. (Nasdaq:LPCN), a specialty pharmaceutical company, today announced positive top-line efficacy results from its ongoing Study of Oral Androgen Replacement (“SOAR”) pivotal Phase 3 clinical study (http://clinicaltrials.gov/show/NCT02081300) evaluating efficacy and safety of LPCN 1021, an Oral Testosterone product, in hypogonadal men with low testosterone (“Low T”). Overall, the study demonstrated positive results with respect to the trial’s primary efficacy endpoint with no serious adverse events. Lipocine continues to expect to file a New Drug Application (“NDA”) with the U.S. Food and Drug Administration (“FDA”) in the second half of 2015.

“We are extremely pleased with the robustness of the top-line results from this study which are consistent with the existing regulatory paradigm for Testosterone Replacement Therapy (“TRT”) product approvals. We believe that LPCN 1021 represents a differentiated TRT for treating hypogonadism in men with the potential to both improve patient compliance and overcome inadvertent testosterone transference risk,” said Dr. Mahesh Patel, Chairman, President and CEO of Lipocine Inc. Dr. Patel further stated, “We look forward to reporting additional safety results from this ongoing study.”

About SOAR Phase 3 Trial:

SOAR is a randomized, open-label, parallel-group, active-controlled, Phase 3 clinical study of oral TRT in hypogonadal males with low testosterone (< 300 ng/dL). In total, 315 subjects at 40 active sites were assigned, such that 210 were randomized to LPCN 1021 and 105 were randomized to the active control, for 52 weeks of treatment. The active control is included for safety assessment. LPCN 1021 subjects were started at 225 mg Testosterone Undecanoate (“TU”) (equivalent to ~ 142 mg of T) twice daily (“BID”) with a standard meal and then dose titrated, if needed, up to 300 mg TU BID or down to 150 mg TU BID based on serum testosterone measured during weeks 3 and 7. The mean age of the subjects in the trial is ~53 yrs with ~91% of the patients < 65 yrs of age.

Results:

Primary statistical analysis was conducted using the Efficacy Population Set (“EPS”). The EPS is defined as subjects randomized into the study with at least one PK profile and no significant protocol deviations and includes imputed missing data by last observation carried forward, N=152. Further analysis was performed using the safety set (“SS”) (any subject that was randomized into the study and took at least one dose, includes imputed missing data by last observation carried forward and as treatment failures if no pharmacokinetic data available, N=210).

Efficacy

The primary efficacy end point is the percentage of subjects with an average 24 hour serum testosterone concentration (“Cavg”) within the normal range, which is defined as 300-1140 ng/dL, after 13 weeks of treatment. The FDA guidelines for primary efficacy success is that at least 75% of the subjects on active treatment achieve a testosterone Cavg within the normal range; and the lower bound of the 95% confidence interval (“CI”) must be greater than 65%.

LPCN 1021 successfully met the FDA primary efficacy guideline. In the EPS analysis, 88% of the subjects on active treatment achieved testosterone Cavg within the normal range with lower bound CI of 82%. Additionally, sensitivity analysis using the SS reaffirmed the finding that LPCN 1021 successfully met the FDA primary efficacy guideline as 80% of the subjects on active treatment achieved testosterone Cavg within the normal range with lower bound CI of 74%.

Other highlights from the efficacy results include:

  • Mean Cavg was 447 ng/dL with coefficient of variance of 37%
  • Less than 12% of the subjects were outside the testosterone Cavg normal range at final dose
  • 85% of subjects arrived at final dose with no more than one titration
  • 51% of subjects were on final dose of 225 mg BID

Safety

Although the safety component of the SOAR trial is on-going, LPCN 1021 treatment has been well tolerated.

LPCN 1021 safety highlights include:

  • 3% of the subjects reported a serious adverse event (“SAE”), with none of the SAEs being drug related
  • All the drug related adverse events were either mild or moderate in intensity (none were severe)
  • Hematocrit (“Hct”) and prostate specific antigen (“PSA”) increases were noted and consistent with other TRT products with one subject discontinued for elevated Hct exceeding pre-specified limits and one subject discontinued for elevated PSA exceeding pre-specified limits

In the EPS analysis, Cmax ≤1500 ng/dL was 83%, Cmax between 1800 and 2500 ng/dL was 4.6% and Cmax > 2500 ng/dL was 2%. Three patients had a Cmax >2500 ng/dL which were transient, isolated and sporadic. Moreover, none of these subjects reported any AEs. Results were generally consistent with those of approved TRT products.

The safety extension phase of the SOAR trial is on-going. The safety extension phase is designed to assess safety information such as metabolites, biomarkers, laboratory values, SAEs and AEs, with subjects on their stable dose regimen in both the treatment arm and the active control arm.

Conference Call and Webcast Details

Conference call details:
Date: September 24, 2014
Time: 8:45 a.m. US Eastern time
Dial-in number: 1 (877) 407-9708

Replay details:
Dates: September 24, 2014 until December 31, 2014
Dial-in number: 1 (877) 660-6853 / 1 (201) 612-7415
Conference ID: 13591771

Webcast details (live broadcast):
URL: https://event.webcasts.com/starthere.jsp?ei=1044036

A replay of the webcast will be available at the Company’s web site, www.lipocine.com, in the “Investor Relations” section.

About LPCN 1021

The current testosterone market is dominated by topical products that are associated with poor patient compliance and FDA “black box” warnings related to inadvertent transfer of testosterone. LPCN 1021 is a twice-a-day, oral product candidate with three simple oral dosing options that we expect will overcome the major shortcomings of existing products.

About Lipocine

Lipocine Inc. is a specialty pharmaceutical company developing innovative pharmaceutical products for use in men’s and women’s health using its proprietary drug delivery technologies. Lipocine’s lead product candidate, LPCN 1021, is currently in Phase 3 and is targeted for testosterone replacement therapy. Additional pipeline candidates include LPCN 1111, a next generation oral testosterone therapy product with potential for once a day dosing, that is currently in Phase 2a testing, and LPCN 1107, which has the potential to become the first oral hydroxyprogesterone caproate product indicated for the prevention of recurrent preterm birth, is currently in Phase 1 testing.

Forward-Looking Statements

This release contains “forward looking statements” that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and includes statements that are not historical facts relating to expectations regarding clinical trials, the potential uses and benefits of Lipocine’s product candidates and product development efforts. Investors are cautioned that all such forward-looking statements involve risks and uncertainties, including, without limitation, the risks related to (i) the receipt of regulatory approvals, (ii) the results of clinical trials, (iii) patient acceptance of Lipocine’s products, (iv) the manufacturing and commercialization of Lipocine’s products, and (v) other risks detailed in Lipocine’s filings with the U.S. Securities and Exchange Commission (the “SEC”), including, without limitation, its Form 10-K and other reports on Form 10-Q and Form 8-K, all of which can be obtained on the Company’s website at www.lipocine.com or on the SEC website at www.sec.gov. Lipocine assumes no obligation to update or revise publicly any forward-looking statements contained in this release, except as required by law.

CONTACT: Morgan Brown
         Executive Vice President & Chief Financial Officer
         Phone: (801) 994-7383
         Email: mb@lipocine.com

         John Woolford
         Phone: (443) 213-0500
         john.woolford@westwicke.com
Wednesday, September 24th, 2014 Uncategorized Comments Off on (LPCN) Positive Top-Line Results Phase 3 LPCN 1021 Oral Testosterone Replacement

(USEI) Launches its On-Line Website for CBD Products

SANTA CLARITA, CA, United States, via ETELIGIS INC., 09/24/2014 – – USEI Cannabis Initiatives Corp, a wholly owned subsidiary of U.S. Energy Initiatives Corporation, Inc., (the Company or USEI) (OTC Pink: USEI) (PINKSHEETS: USEI), announces today that USEI along with its JV partners have collectively launched their website for the sale of CBD products to its patients and the general public. USEI recently announced the partnerships with Angel Swanson (http://thecannabisemporium.com/in-the-news.html) and her team, to open CBD theme stores in the state of Washington and we are excited about the potential of this enterprise.

Our The Ultimate Cure stores and brand featured a wide range of cannabis related products that featured a high concentration of CBD not THC. The two (2) stores are located in the State of Washington (one in Tacoma and one in Puyallup) service cannabis patients opened for business on August 1, 2014 (http://www.useicannabis.com/web/washington-partnerships/). Our joint venture further is responsible for developing a new line of edible infused products (with CBD) that we have already sold hundreds of them in our stores and events under the brand The Ultimate Cure and we have had numerous patients, have significant benefits from using our topicals, tinctures, oils and edible products that include pain relief, epilepsy, migraines, cancer related relief, PTSD, anxiety and more.

According to Anthony K. Miller CEO This site (www.theuccbdshop.com) is still a work in progress however, it does feature products that we currently sell in our stores.

(https://www.youtube.com/watch?v=56uFDHcpHss). We have selected CBD products as our initial focus, primarily because of its significant medical benefits to treat patients with medicine without the psychoactive effects of cannabis (http://www.useicannabis.com/web/ …. 10 benefits of CBD Cannabis). This website will be updated with many images and products in the coming weeks. This press release has a number of links in it and I invite investors and interested parties to examine the content of these links to understand the strength of USEIs business plan. This month we also provided an update on the activities of this firm and that can be found at the following video link (https://www.youtube.com/watch?v=uh6bXRg9dXU&feature=youtu.be).

The management of USEI is currently working on a number of projects and a progress report on some of them will be forthcoming. We have a cannabis grow project with American Green in development, the expansion of our Ultimate Cure retail stores, edibles, the expansion of our Real McCoy brand and the active procurement of a significant interest in a recreational license in the state of Washington; that are in development. We have a robust business model and we believe that our future will be long, profitable and substantial in this cannabis sector; again the source of what USEI is doing is solely the company itself not outside sources that have no clue what the company is actually doing, just wacky concocted scenariosthe Management of USEI would like to formally thank its loyal investors and supporters and we believe that in due season rewards will ultimately be reaped finally, commented Miller.

About U.S. Energy Initiatives:

U.S. Energy Initiatives Corporation is a diverse (OTC Pink: USEI) energy firm. This firm started in 1996 and has had a long successful business history of developing its business strategies. Management’s new goal is to business and to build a dynamic and diverse firm. From 2014-2015 U.S. Energy Initiatives will center on hemp to energy, everything cannabis related and developing products and services for the marketplace. Our goal here is to become an environmentally responsible firm, marketing our products to a worldwide audience to produce significant revenue and add value for our shareholders. We will continue to develop products for the Real McCoy brand in the coming months; including some products targeted to growers of cannabis. We have very ambitious goals and objectives for USEI Cannabis and we believe that we will have a very long presence in Colorado and Washington, and wherever cannabis is legal. Our objective is to create a foundation that will be instrumental in our continued conquest to capture our market-share and create viable products that meet our goals and objectives for these markets. For more information regarding our strategies it can be found on the companys website @ www.useicannabis.com/web/.

DISCLOSURES:

“Safe Harbor” This press release contains forward-looking statements including statements regarding the timing of the revenue from the partnership and the partnership’s success. The words “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “will,” “expect” and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Important factors that could cause actual results to differ from those in the forward looking statements include consumer reaction to our Cannabis products and new regulations which affect the distribution of these products. Further information on our risk factors is contained in our filings with the OTC Markets. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.

CONTACT:

U.S. Energy Initiatives Corporation, Inc.

Investor Relations

Ph: 866 922-1116

Email: info@usenergyinit.com

Web: www.usenergyinit.com

Web: www.useicannabis.com

Wednesday, September 24th, 2014 Uncategorized Comments Off on (USEI) Launches its On-Line Website for CBD Products

(PLCSF) & Viveve Announce Completion of Merger and Private Placement

SUNNYVALE, CA–(September 24, 2014) – Viveve, Inc. (“Viveve”), a company focused on women’s health, today announced that, effective September 23, 2014, it has completed its merger with PLC Systems, Inc. (PINKSHEETS: PLCSF) (“PLC”), initially announced on May 14th. Viveve will operate as a wholly-owned subsidiary of PLC and PLC will now be known as Viveve Medical, Inc. (“Viveve Medical”). Viveve will compete in the women’s health market with a focus on the Viveve® System to improve women’s overall sexual well-being and quality of life, will retain all its personnel and continue to be headquartered in Sunnyvale, CA. In connection with the merger, Viveve Medical will issue 4,686,878 shares of common stock. Beginning approximately October 22nd, the stock will trade under the symbol VIVMF.

Effective as of the closing, Patricia Scheller, formerly the Chief Executive Officer of Viveve, became the CEO and a Director of Viveve Medical and Scott Durbin, who served as the Chief Financial Officer of Viveve, became the CFO of Viveve Medical.

Concurrent with the merger, Viveve Medical completed a private placement for total gross proceeds of approximately $6 million (including approximately $1.5 million of bridge debt conversion). As a result, Viveve Medical issued 11,305,567 shares of common stock and 5-year warrants to purchase up to 940,189 shares of common stock at an exercise price of $0.53 per share. Upon closing of the merger and private placement, Viveve Medical has approximately 18 million shares of common stock issued and outstanding. Proceeds from the private placement are expected to be used for research and development, to broaden Viveve’s commercial efforts in the three countries where the Viveve® System is available for sale, and to expand into the European market. The private placement included 5AM Ventures, GBS Venture Partners, Alta BioEquities and several other investors.

At the effective time of the merger, PLC divested its ownership of its former operating subsidiaries, PLC Medical Systems, Inc. and PLC Systemas Medicos Internacionais, which will operate as independent entities going forward under new ownership.

“This transaction positions Viveve to increase market awareness about the condition of vaginal introital laxity — a condition that affects millions of women worldwide — and its profound impact on women’s lives,” commented Patricia Scheller, CEO of Viveve Medical. “Given the growing concern surrounding women’s sexual health issues, the large market opportunity, and the lack of effective, non-invasive treatments for vaginal laxity, I believe Viveve is well-positioned for growth.”

Evolution Venture Partners acted as advisor to the Company on this transaction, and Richardson Patel served as its legal advisor.

About Viveve
Viveve, Inc., the operating subsidiary of Viveve Medical, Inc., is a women’s health company passionately committed to advancing new solutions to improve women’s overall well-being and quality of life. The company’s lead product, the Viveve® System, is a non-surgical, non-ablative medical device that remodels collagen and restores tissue. The Viveve System treats the condition of vaginal laxity, which is the result of the over-stretching of tissue during childbirth, which can result in a decrease in sexual function and physical sensation. Physician surveys indicate that vaginal laxity is the number one post-delivery physical change for women, being more prevalent than weight gain, urinary incontinence or stretch marks. The Viveve Treatment uses patented, reverse-thermal gradient radiofrequency technology to tighten the tissues of the vaginal introitus (opening) and requires only a 30-minute out-patient treatment in a physician’s office. The Viveve System has received regulatory approval in Europe, Canada and Hong Kong and is available through physician import license in Japan. It is currently not available for sale in the U.S.

Safe Harbor Statement
All statements in this press release that are not based on historical fact are “forward looking statements”. While management has based any forward looking statements included in this press release on its current expectations, the information on which such expectations were based may change. These forward looking statements rely on a number of assumptions concerning future events and are subject to a number of risks, uncertainties and other factors, many of which are outside of our control, which could cause actual results to materially differ from such statements. Such risks, uncertainties, and other factors include, but are not limited to, the fluctuation of global economic conditions, the performance of management and our employees, our ability to obtain financing, competition, general economic conditions and other factors that are to be detailed in our periodic and current reports available for review at www.sec.gov. Furthermore, we operate in a highly competitive and rapidly changing environment where new and unanticipated risks may arise. Accordingly, investors should not place any reliance on forward-looking statements as a prediction of actual results. We disclaim any intention to, and undertake no obligation to, update or revise forward-looking statements to reflect events or circumstances that subsequently occur or of which we hereafter become aware.

Viveve, Viveve System, Viveve Treatment and Viveve Procedure are registered trademarks of Viveve, Inc.

Contact:
Investor Relations
Booke and Company Inc.
600 Third Ave.
New York, NY 10016
212-490-9095
admin@bookeandco.com

Wednesday, September 24th, 2014 Uncategorized Comments Off on (PLCSF) & Viveve Announce Completion of Merger and Private Placement

(AJAC) Announces Kendall A. Smith Begins as BOD Member

Company Plans to Become Single Focused, Divest Subsidiaries With Plantinga to Lead Charge! Energy Storage and Propel Management Group

LAKE ELSINORE, CA–(Sep 24, 2014) – Aja Cannafacturing, Inc. (OTCQB: AJAC) announced today Mr. Kendall A. Smith is now a member of the Board of Directors and started his first day by participating in the Company’s Board meeting yesterday. During that meeting, the Company announced the Board adopted a plan that set a clear path for the Company’s future by designating a leader for each entity. Each leader will build their management team as quickly as possible and develop and execute a definitive plan that includes the raising of new capital.

The Company stated Mr. Smith, a recent addition to its Board of Directors, was selected to become the Chief Executive Officer and President tentatively effective October 1, 2014, with Mr. Plantinga continuing as its Chairman of the Board of Directors for only that period of time necessary to resolve any legacy issues outstanding. The Company will identify and review candidates to appoint to its Board of Directors to expand its base of support in its pursuit of new capital and other new resources. This change in leadership solidifies the Company’s commitment to its new business model and changes how the Company will operate. Mr. Smith is very familiar in the hemp and cannabis space and has the vision for the company to grow and exploit its recently adopted business model.

Charge! Energy Storage, Inc. (CES), its wholly-owned subsidiary, will retain Scott Plantinga as its President, Chief Executive Officer and Chairman of the Board of Directors and seek new members to appoint to its Board of Directors. CES will be spun off in a deal that is currently being negotiated by its parent’s Board of Directors. This news follows the announcement on September 15, 2014 that Aja Cannafacturing, Inc. had approved divestiture of Charge!, pending regulatory approval. A highlight of the divestiture plan is that shareholders, as of a date soon to be announced, are scheduled to receive a share in both AJAC and CES on a 1 for 1 pro-rata basis, thus providing greater value and opportunity for shareholders.

In follow up to the previous announcement that Charge! Energy Storage will attend ESNA Expo 2014, Plantinga stated, “We are excited to continue our discussion and development of our strategic partnership with the executive management of FGY Energy Storage Research Institute (FGY Energy Storage Research Institute Co., Ltd. a Jiang Su, China) next week at the ESNA (Energy Storage North America) Expo and Conference in San Jose, California, September 30 – October 2, 2014. For those not familiar with the event, the Energy Storage North America is the largest grid energy storage event in North America and features critical insights into market developments and technology integration, and will have over 1,000 leading customers in attendance along with technology providers and partners that can participate in over 40 conference sessions, hands-on workshops and site tours in Silicon Valley.”

Mr. Plantinga added, “The Investor Deck for CES is complete and the 2-year detailed budget projections have been finalized so we are excited to continue our discussions with this strategic partner as well as other investor groups. Since we will also be attending the show together I look forward to making introductions and speaking with all my colleagues in the energy storage field, some of whom I haven’t seen since last year’s Energy Storage North American conference.”

About Aja Cannafacturing, Inc.

Aja Cannafacturing, Inc. (OTCQB: AJAC) operations are focused on being the pioneering force in the cannabis and Industrial Hemp industry by the select breeding and cultivation of application-specific, proprietary cannabis seed. Through these methods, Aja Cannafacturing seeks to maximize the potential of every harvest. Becoming a leading supplier of raw cannabis material for industry specific applications such as building materials (Hempcrete), automotive (biofuels), plastics (healthcare) and textiles (fabrics), among others, positions Aja Cannafacturing at the forefront of a new domestic industrial revolution.

Charge! Energy Storage, Inc. is a wholly-owned subsidiary of AJAC. Charge! Energy Storage is a designer and developer of GIIRS-rated energy storage devices for residential, commercial, and light industrial markets and products that deliver clean stationary and portable electrical energy. Charge! has made a broad reaching commitment to create reliable and affordable hi-tech energy storage systems for all commercial and residential applications.

Propel Management Group Inc. (PMG) provides a full range of program management, acquisition, and lifecycle support services to its customers. PMG is at the forefront of integrating acquisition, logistics, engineering, and technology disciplines into a comprehensive lifecycle management approach. PMG continually strives to improve the process of developing, procuring, and sustaining its customers’ systems to achieve their overarching goals of transformation, consolidation, and efficiency. Its Direct-to-Consumer business delivers comprehensive call center and online marketing solutions to brands seeking maximum reach and return on investment (ROI).

Forward-looking & Safe Harbor Statement
Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and those statements are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the Company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. The Company cautions that these forward-looking statements are further qualified by other factors. The Company undertakes no obligation to publicly update or revise any statements in this release, whether as a result of new information, future events or otherwise.

  • Oil, Gas, & Consumable Fuels
  • Investment & Company Information
  • Energy Storage
  • North America

Investor Inquiries:
Aja Cannafacturing, Inc.
IR@AjaCannafacturing.com
(714) 733-1412 (Investor Relations)

Wednesday, September 24th, 2014 Uncategorized Comments Off on (AJAC) Announces Kendall A. Smith Begins as BOD Member

(EDWY) Engages Capital Law LLP as Counsel for Chill Removal, Announces Its Activities

HOUSTON, TX, United States, via ETELIGIS INC., 09/24/2014 – – eDoorways International Corporation (OTC Pink: EDWY) (PINKSHEETS: EDWY) has retained Capital Law LLP, a Washington-based firm specializing in securities-related issues, as its Special Securities Counsel. The agreement calls for Capital Law LLP to assist EDWY in determining whether, and if so, why a restriction or chill was placed on the Companys securities on electronic deposit with Depository Trust and Clearing Corp (DTC). The goal of the representation is to remove the restriction or chill so the Company can again have its securities transferred and electronically cleared through DTCs book entry services without restriction.

We are taking effective steps to move the Company forward. The move to resolve the chill issue is one of several EDWY activities since the resignation of Mr. Gary Kimmons, its former CEO, in August, 2013 and his subsequent relinquishment of voting control. Pacific Stock Transfer recently came on board as our new transfer agent. We also are seeking to complete our audit to become fully compliant as a SEC-reporting entity. We are searching to find a satisfactory replacement for the vacated CEO position. An overarching goal will be to accomplish these and other objectives while maintaining a tight share structure.

EDWY is actively pursuing our business mission as an incubator that secures funding for promising technology ventures and takes them public. Our recent activities and accomplishments in this regard will be discussed in forthcoming announcements.

“I am excited to see what we can accomplish.” stated Arne M Ray, Director Tempore. “I believe eDoorways is effectively positioning itself to achieve its business objectives.”

Please visit our website at www.edoorwayscorp.com for more information on eDoorways International. Or you may email us at info@edoorwayscorp.com.

Safe Harbor for Forward-Looking Statements:

Except for historical information contained herein, the statements in this press release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which may cause the company’s actual results in future periods to differ materially from forecasted results. These risks and uncertainties include, among other things, product price volatility, product demand, market competition, risk inherent in the company’s domestic and international operations, imprecision in estimating product reserves and the company’s ability to replace and expand its holdings.

CONTACT:

Arne M Ray, Director Tempore

Houston, Texas

(713) 627-7111

info@edoorwayscorp.com

Wednesday, September 24th, 2014 Uncategorized Comments Off on (EDWY) Engages Capital Law LLP as Counsel for Chill Removal, Announces Its Activities

(GWPC) Release of the FDA Cleared “HIV 1&2” Rapid Diagnostic Test

ANAHEIM, Calif., Sept. 23, 2014 /PRNewswire/ — This test can detect HIV infection if used 3 months after a risk event. A “risk event” is defined by activities that can transfer body fluids from one person to another, including blood transfusions, tattoos, or use of any shared needles.

  • An in-vitro diagnostic home-use test for HIV (HIV-1 and HIV-2) in oral fluid. This HIV test works by looking for your body’s response to fighting the HIV virus (antibodies).
    Provides results in 20 minutes, enabling patients to learn their status in a single visit and allows HIV positive patients to be connected to care immediately.
  • Flexible
    Approved for oral fluid, plasma, fingerstick or venipuncture whole blood specimens. Ideal for both clinical and non-clinical settings.
  • Accurate
    Greater than 99% agreement with confirmatory Western blot.1
  • Simple
    CLIA-waived for oral fluid, fingerstick and venipuncture whole blood and offers the ability to test in non-traditional testing environments, such as outreach programs and mobile testing clinics.

Inspired by its slogan, Love Life. Live Long.”  WholeHealth is committed to building long-term relationships with the medical and healthcare professional and the patients, helping save lives.

WholeHealth Products Inc. your partner in the “Business of Science”

www.WholeHealth-Products.com

Certain information set forth in this fact sheet may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of WholeHealth Products Inc, including, but not limited to, risks associated with the impact of general economic conditions, industry conditions, dependence upon regulatory approvals, and the uncertainty of obtaining additional financing. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements.

Headquartered in Anaheim, California, WholeHealth Products. (OTC: GWPC) is a diversified company comprised of several specialized partners focused on leveraging the power and convenience of advanced technology and the proven expertise of its team of professionals to improve the fundamental business of health and wellness. WholeHealth Products’ line of more than 10 professional diagnostic tests (Strep A, H. Pylori, Influenza A, Influenza B, Influenza A&B Combo, Fecal Occult Blood, Pregnancy, Ovulation, Menopause, Mononucleosis, Cholesterol, Troponin I, Drug of Abuse Tests, and NOW HIV 1&2 for hospitals, doctors, clinics and healthcare centers, and its more than 8 retail consumer tests is proud to announce an addition to its line of rapid diagnostic tests.

Tuesday, September 23rd, 2014 Uncategorized Comments Off on (GWPC) Release of the FDA Cleared “HIV 1&2” Rapid Diagnostic Test

(CBWP) Shareholders Ratify Acquisition Of Cannabis Consumer Goods Company

BELLEVUE, Wash., Sept. 23, 2014  — Canna Brands, Inc. (OTC Pink “CBWP”) (“Canna Brands” or the “Company”) today announced its July 29, 2014 acquisition of Bothell, WA, cannabis consumer goods company Canna & Canna Inc., was overwhelmingly ratified at a Special Meeting of shareholders held September 19, 2014 in Bellevue WA.  At the Special Meeting, shareholders also overwhelmingly approved the change of corporate name recommended by the Board of Directors, from Crownbutte Wind Power Inc. to Canna Brands, Inc., reflecting the aforementioned acquisition and new principal business of the Company.

The business of Canna Brands is developing and licensing uniquely branded specialty goods targeted to cannabis consumers residing in the states of Colorado and Washington where the recreational consumption of cannabis infused products, such as bottled sodas, coffee beverages, baked goods and others, is legal for persons 21 years or over.

CEO Mark Schaftlein stated:

“The Board’s vision at the outset was to make an acquisition at the epicenter of a burgeoning new consumer goods industry – cannabis infused products. At the Special Meeting, 84% of our shareholders participated in person or by proxy – an excellent response – and fully 99% of those participating endorsed the acquisition of a cannabis consumer goods company. Having the Board’s vision confirmed by this large a majority of shareholders gives us real momentum to grow the Company.”

In accordance with standard procedures, Canna Brands advised the Financial Industry Regulatory Authority (FINRA) in advance of the corporate actions to be taken at the Special Meeting of shareholders and expects to be issued a new ticker symbol by FINRA reflecting its name change in the near term.

Tuesday, September 23rd, 2014 Uncategorized Comments Off on (CBWP) Shareholders Ratify Acquisition Of Cannabis Consumer Goods Company